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ABSTRACT

THE POTENTIAL ROLE FOR capB IN THE PATHOGENESIS OF FRANCISELLA
TULARENSIS
By MAJ Eric R. Fleming, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2009
Director: Dennis E. Ohman, Ph.D.
Chair, Department of Microbiology and Immunology

Francisella tularensis was a facultative intracellular pathogen and a gram-negative
coccobacillus which has been categorized by the CDC as a potential class A select agent
due to its highly infectious properties and high mortality rates. Francisella tularensis
was also responsible for the zoonotic disease tularemia, which was usually transmitted by
arthropod vectors or via contact with infected animals. Francisella tularensis subspecies
novicida has been used by many researchers in genetic pathogenesis experiments to try to
elucidate genes responsible for virulence factors. One of these virulence factors was a
capsular material which has been thought to be involved in either increasing
pathogenicity or infectivity of this organism upon engulfment by its principal host cell,
the macrophage. There were many potential genetic loci which may be involved in this
xiv

biosynthetic process of encapsulation. One such locus has excellent homology to the
capsule biosynthesis operon of Bacillus anthracis, which, under certain conditions,
creates a polyglutamic acid capsule (PGA). A transposon mutation in the amide ligase
(capB) in LVS has a reduced virulence in murine infection models.

I wished to

investigate whether Francisella novicida was capable of producing such a capsule and
under which environmental conditions this capsule was made. I have created a sitedirected mutant of the capB gene in Francisella novicida U112 using targeted
mutagenesis via PCR SOEing and have introduced this mutation via electroporation of a
suicide vector. I have tested our mutant against preimmune serum treatments and have
shown reduced viability as well as a reduced capacity for replication inside RAW 264.7
murine macrophages. I assayed for production of a PGA capsule via immunodot blot and
electron microscopy as well as analysis by mass spectrophotometry of capsular extracts.
I also tested various media constituents and different environmental conditions to
determine which external stimuli may contribute to PGA capsule biosynthesis as well as
regulatory changes in transcript levels of this operon.

xv

CHAPTER ONE: INTRODUCTION

Background
Francisella tularensis was a gram negative coccobacillus bacteria and was
classified as a facultative intracellular pathogen, in which it can survive outside a host in
the environment. It was highly infectious, with as few as ten organisms causing disease
in compromised individuals, and can be easily disseminated. It was classified by the
Center of Disease Control and Prevention as a category A select agent. The organisms,
viruses, and toxins which comprise this list were known to have the potential to cause
widespread disease, produce high levels of morbidity and mortality if not treated, and
usually require specialized care and therapy for resolution. Francisella tularensis causes
the zoonotic disease tularemia, which originally was discovered in Tulare County,
California causing a plaque-like illness in local ground squirrels in 1911. The organism
isolated from these animals was originally called Bacterium tularense, after the site of
disease origin. In 1947, it was later renamed after the famous public health surgeon, Dr.
Edward Francis, who dedicated his life to the study of this organism and the disease it
causes. Tularemia was usually associated with rodents, rabbits, muskrats, and voles and
has been nicknamed rabbit fever. In the 1930s and 40s, large waterborne outbreaks of
tularemia occurred in regions of the Soviet Union and Europe. The largest outbreak on
record occurred in Sweden in 1966 through 1967, in which over 600 farmers became
infected due to the aerosolization of bacteria in rodent-infested hay (47, 111).

Transmission
Tularemia was usually transmitted in one of four ways: direct contact with
infected animals, arthropod-borne, ingestion, or aerosolization. The severity of disease
can be associated with the route of infection. There were many known reservoirs of
Francisella, including 14 species of ticks, 6 species of flies, many known mosquito
species, several hundred species of mammals, and several bird species. While most cases
in the United States involve ticks or mammal exposure, there was a known rodentmosquito cycle which takes place in the northern climes of Russia and Sweden. Direct
contamination was usually due to the handling of skins or tissue of infected animals, and
was mostly associated with the occupational hazards of animal handlers or farmers. Bites
from infected animals have resulted in transmission, however this occurs rather
infrequently. Ticks infected with Francisella were usually infective for life and there
was evidence of transovarial transmission, in which female ticks pass the bacteria on to
their offspring.

Tick species known to transmit tularemia include Dermacentor

andersonii, Dermacentor variabilis, and Amblyomma americanum.

The mosquito

species of Aedes, Anopheles, and Culex have been known to transmit tularemia as well.
The deerfly Chrysops discalis was also known to transmit this disease, although
infrequently. Humans were usually accidental hosts in this life cycle. Ingestion of
relatively larger amounts of bacteria has been the source of waterborne outbreaks, and
disease has resulted from the ingestion of contaminated meat. Some water borne cases
have been affiliated with amoebae, such as Acanthamoeba, and it was known that these
bacteria can persist in these single-celled organisms for some time. Aerosolization of
2

bacteria due to contaminated hay and soil as well as laboratory accidents have produced
many instances of pneumonic tularemia. The fairly recent occurrence of exposure to
laboratory workers at the clinical microbiology lab at Boston Medical Center clarifies the
importance of established select agent protocols and laboratory notification of potentially
dangerous organisms (152, 156). There have been no reported incidences of person to
person transmission.

Utilization as bioweapon
Due to its infectivity and its ease of dissemination, Francisella tularensis has
been an agent of interest to the military as a biological weapon and was developed and
mass produced in both the United States and the Soviet Union in the early 1950s. One of
the most virulent strains of Francisella was weaponized for use in the M143 bursting
spherical bomblet. It was believed that in the Soviet Union, strains of Francisella were
engineered to withstand various antibiotics and vaccine therapies as late as 1990. In
1972, the Biological and Toxic Weapons Convention was signed by the United States
prohibiting the development, production and stockpiling of microbes or their poisonous
products except in amounts necessary for protective and peaceful research. As of 1996,
137 different countries had ratified this treaty, however it was believed that several
countries have ignored the specifics of this treaty and have continued production of
biological weapons (111).
It has been suggested by Dr. Ken Alibek and a former Russian LTC that Russia
used tularemia as a bioweapon at the onset of the Battle of Stalingrad in the fall of 1942.
3

It was recorded that Russia had already lost a least a million soldiers that preceding year,
and when it become clear that the German forces (6th and 17th Armies) were pushing
toward Stalingrad, Stalin ordered Order 227, in which “every granule of Soviet soil must
be defended to the last drop of blood.” That fall over one hundred thousand cases of
tularemia (the majority of these were pulmonary infections) befell the soldiers, first the
Germans, but then the Russians too were affected. Subsequent reports, however, have
cast doubt on these suggestions, as tularemia was endemic to these regions of Russia, and
that the severe conditions of the front promoted these infections. It has been reported that
the regional crops had not been harvested and that by winter, the number of rodents
cohabiting with soldiers was extreme. Soldiers from both sides were bedding in straw as
well as eating rations frequently tainted with dead rodents (1).
In 1969, the World Health Organization (WHO) estimated that if 50 kg of virulent
F. tularensis particles were aerosolized over a city with 5 million people, the result would
be 250,000 illnesses and 19,000 deaths. Illness would be expected to persist for several
weeks and disease relapses would occur during the following weeks or months. Recently,
the Centers for Disease Control and Prevention (CDC) estimated the economic impact
associated with an outbreak of tularemia to be $5.4 billion for every 100,000 people
exposed (total base cost to society) (75, 187).

Epidemiology, disease, and treatment
Tularemia was usually found in the northern hemisphere in countries such as the
United States, Russia, Europe, Japan, and Scandinavia. Cases have been reported as far
4

as south as Australia. In the U.S., about 200 cases were reported each year and were
usually located in Midwestern states, such as Oklahoma, Missouri, and Arkansas.
Human disease can usually be linked to increased prevalence of tularemia in local
wildlife.
Tularemia as a disease usually manifests itself in one of six clinical syndromes:
ulceroglandular (the most prevalent form), glandular, oropharyngeal, oculoglandular,
typhoidal, and pulmonary (usually the most lethal). These manifestations depend on the
route of infection, the particular strain, and the inoculum size. All of these forms,
however, usually start with headache, sudden fever, myalgia, and chills after three to ten
days of incubation. Bacteria were usually be found disseminated to the spleen, liver,
lungs, kidneys, and other sites which harbor cells of the reticuloendothelial system. The
glandular symptoms were the result of infected lymphatics and present as the classic
enlarged buboes and lymphadenopathy similar to bubonic plaque. The most mortality
(30 to 60%) was seen with typhoidal and pulmonary tularemia, which, if left untreated,
may result in shock and pneumonia, respectively. Pulmonary tularemia was usually due
to the inhalation of infectious organisms via aerosolization (47).
Treatment of this disease can be successful, however, history has shown that early
and the correct antibiotic regimen against tularemia was paramount. Streptomycin and
gentamicin were effective against Francisella and were bactericidal antibiotics.
Ciprofloxacin has been a favorite choice of treatment due to its efficacy in pediatric cases
as well as against relapses of diseases when initial therapy was not successful.
Doxycycline was another favorite due to its low cost.
5

Bacteriostatic drugs against

Francisella include tetracycline and chloramphenicol, which require longer treatment
regimens. It has been shown that Francisella was resistant to most beta-lactams and
azithromycin via in vitro suspectibility tests (43).

Description of Francisella subspecies
There were five main subspecies of Francisella tularensis:

tularensis,

mediasiatica, holarctica, novicida, and japonica. Francisella tularensis tularensis has
been classified as type A, has the highest virulence of the subspecies, and requires
manipulation in a BSL-3 laboratory. Francisella tularensis holarctica has less virulence
and was classified as a type B organism. One strain of holarctica, LVS (live vaccine
strain), has been used as a vaccine in the past against tularemic infections, however, the
identification of the attenuation of this strain has never been uncovered which prevents its
licensure with the FDA. Francisella tularensis novicida has been shown to be less
virulent to humans and presents a tularemia like illness in animal models. Francisella
novicida has nearly identical 16S ribosomal DNA to Francisella tularensis, but lacks a
second copy of the Francisella pathogenicity island (FPI) which was essential to
intracellular growth in macrophages (33, 115). It has also been established that novicida
has a functioning restriction system, making transformation experiments more difficult.
These characteristics have made this strain a choice of many researchers hoping to
uncover the many various virulence factors responsible for its pathogenesis.

This

organism has many ORFs that do not match with known proteins of other bacteria, and
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were deemed unique. In general, the Francisella genome has a relatively low G+C
content (34%) and a small length of ~ 1.8Mbp (16).

Bacterial capsule as a virulence factor
Little was known regarding the virulence factors responsible for Francisella’s
pathogenesis. No information has been found regarding the presence of secreted toxins,
although evidence of genes for pili formation and type I (ATP-binding cassette proteins)
secretion exist (192). It was also known that the lipopolysaccharide (LPS) for
Francisella does not elicit the same type of immune response characteristic of gramnegative bacteria. It does not cause the induction of IL-1 nor the strong induction of
TNFα from macrophages.
Many bacteria produce a protective barrier around themselves traditionally
comprised of polysaccharides and attached to either the outer membrane or the
peptidoglycan layer called a capsule. This protective barrier can have many different
properties depending on the bacteria and the nature of the capsule. Usually the capsule
was made of a polymer of a weakly immunogenic material which can be used to aid the
bacteria in avoiding aspects of both the innate and adaptive immune responses. Some
capsules were able to inactivate complement by disrupting the formation of the MAC
complex on the bacterial surface. Others mask pathogen-associated molecular patterns
that may be recognized by instruments of the adaptive immune response. Some capsules
give their bacteria adhesive properties so that may cluster and inhibit antibiotics or other
bactericidal materials. Still others provide an ionic shell which aid certain bacteria from
7

desiccation as well as act as a hydrophilic barrier which can also protect the bacteria
during stringent conditions. It can also act as an ionphilic barrier for important cations
needed by the bacteria cell for metabolism. Historically, it has been shown that with
many bacteria, if they were stripped of their capsular material, that the virulence potential
for that organism in in vitro infection experiments or animal models was greatly reduced.
A classic example of this would be the smooth:rough Streptococcus experiments
performed by Avery.

The bacterial capsule of Francisella has been an object of

contention amongst many researchers, many of which, in years past, questioned its
existence. However, Dr. Hood’s analysis of the capsular material recovered from the
virulent F. tularensis Schu S4 strain showed evidence of mannose, rhamnose, galactose,
and two forms of fatty acid (68). It has been said however, that these samples may have
been contaminated with LPS, and that additional analysis was necessary.

Dr.

Cherwonogrodsky published a seminal paper in 1994 in which he demonstrated an
increase in both encapsulation and virulence with repeated growth of Francisella in the
synthetic Chamberlain’s media (32). Although there was no isolation or analysis of
capsular material, the capsule was visualized by transmission electron microscopy and
the reduction in viability of test animals was demonstrated in infection models. In recent
years, Drs. Apicella and Inzana have elucidated the capsule of Francisella using
immunoelectron microscopy with antibodies specific for individual sugars which
comprise the capsule. Its relevance and role in pathogeneticity was still questioned,
however, as Dr. Golovliov has presented data showing the loss of capsular material upon
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phagolysosome entry by the bacteria in macrophage infection and that the capsular
material may be involved in the actual escape of bacteria from the phagolysosome (57).
Genetically, the genes responsible for biosynthesis of this polysaccharide capsule
have been elucidated and were in proximity with the genes responsible for O-antigen
synthesis. Mutants have been made of several of these genes (manC, manB, and GGT)
and the loss of capsular material has been observed (unpublished material). There were,
however, other genes present in Francisella which could potentially encode for a protein
capsule.

Characteristics of polyglutamic acid
Many of the Bacillus species encode for a capsule which consists of poly-γglutamic acid (PGA), a nonribosomal polyamino polymer that can be covalently attached
or secreted from the bacteria. PGA was found usually in gram positive bacteria and when
attached, was anchored to the peptidoglycan layer. Attachment of PGA to this layer was
dependent on the expression of capD, which encodes a γ-glutamyltranspeptidase, which
was also thought to be integral in PGA degradation.

A recent capD mutation in

Francisella (referred to as GGT) was found to have low intracellular viability not due to
effects on polymerization of PGA, but due to its importance in the breakdown of
glutathione for cysteine acquistion (2). PGA can be formed entirely of D-glutamate, as
was the case in Bacillus anthracis, or consist of both isomer forms, D+L. Polymers
consisting solely of L-glutamate were the rarest form of PGA. Isomers of glutamate were
possible via glutamate racemase, which exists in Francisella.
9

The potential for

isomerization was important as polymers consisting of a singular form of glutamate will
act as a thymus-independent type 2 antigen and will be incapable of inducing
immunoglobulin class switching (183). It has been shown that PGA provides certain
bacteria (ie. Staphylococcus epidermidis) salt tolerance and also gives B. anthracis
antiphagocytic properties. PGA may also be a storage of both nitrogen and carbon in
periods of starvation. PGA was polyanionic in nature and was highly water soluble,
which aids in its hydrophilic properties (25, 63). Measurement of PGA from bacteria can
be difficult as traditional protein assays such as Bradford and Lowery were not effective
(1.25 mg/ml of L-glutamic acid solution measures as 0.42 µg/ml in the Bradford assay).
PGA also does not stain with Coomassie blue in SDS-PAGE experiments (188). Polymer
size usually varies due to the organism, but can measure from 160 kDa to 1500 kDa (>
1000 residues).

Gene operon of polyglutamic acid
In B. anthracis, this protein capsule operon was encoded by the plasmid OX2,
which may have the propensity to transpose to other bacteria (12, 60). This operon
consists of capA, capB, capC, capD, and capE genes (6). Some ambiguity still exists
regarding whether capE was essential for polymerization to occur, as PGA has been
created in reengineered tobacco plants with only the A, B, and C orthologs (169). The
genes for capA, capB, and capC were located together in the Francisella novicida U112
genome at position 1272800, while it was believed that the analog for capD was located
upstream at position 1229837. There were many lines of evidence that point to the
10

Figure 1 A and B. The structure of polyglutamic acid, the organisms which produce
PGA, and confirmation of known polymers. A) PGA was made up as an anionic
polymer of glutamic acid residues connected by gamma linkages, which were resistant to
protease activity. These linkages provide PGA with specific properties. B) Many
organisms were known to produce PGA and were capable of several different
configurations of polymer, depending on the enantiomers of glutamate available.

11

adapted from Candela T. and Fouet A. Molecular Microbiology 60: 1091-98
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production of a PGA capsule by Francisella. First, several bacteria have been identified
to contain the cap operon within their genome, with a few of these not being traditional
gram-positive bacteria, such as Leptospira interrogans and Fusobacterium nucleatum
(79). Second, Francisella has excellent homology (>50%) to most of these genes, and
ablation of several of these genes has phenotypic effects (161). Third, it has been shown
that gram-negative bacteria were capable of producing PGA. Dr. Ashiuchi reengineered
E. coli bacteria with expression vectors to express the cap operon in an attempt to massproduce PGA for industrial purposes. PGA has many uses such as a food preservative, a
cryoprotectant, a cosmetic thickener, and as a biological adhesive. Dr. Ashiuchi found
that the reengineered E. coli could produce PGA, however, at a much lesser yield (9).
And finally, Dr. Su, in his transposon mutagenesis experiments of LVS, demonstrated a
substantial decrease in virulence of the capB mutant in murine animal co-infection
models. This data was supported by the generation of site-directed mutagenesis of this
same gene to rule out the effects of potential transposon integration at other sites besides
this gene of interest. Similar attenuation of virulence was seen (161).
The capB gene of this operon traditionally encodes an amide ligase, which was
responsible for the gamma bond linkage between molecules of glutamic acid. This was
the bonding of the gamma carboxyl group of glutamate to the amine group of the next
glutamate. This linkage gives the polymer additional properties beyond the usual alpha
peptide linkage. The gamma linkage was resistant to proteases unlike the alpha linkage.
The polymerization of PGA requires ATP and the genetic sequence of capB has a
consensus ATPase motif early in its sequence (GIRGKS). Unfortunately, the membrane
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structure and organization of this enzyme and its protein-protein interactions have not
been uncovered as isolation of this membrane protein complex was unstable. It was
believed that CapB and CapC form a complex together due to the increase in ATPase
activity and that these proteins were mainly involved in polymerization (25, 107).

Mutagenesis of Francisella
Transposon mutagenesis of Francisella has been successful in elucidating many
gene functions of unknown reading frames as well as genes required for intracellular
growth, but for a long time, no confident allelic exchange system existed for site-directed
mutagenesis of particular genes.

Initial vectors designed for allelic exchange in

Francisella lacked species-specific promoters driving various antibiotic cassettes.
Similar transposon elements without Francisella-specific promoters also failed to be
successful instruments of mutagenesis (54). The development of the pFNLTP series of
plasmids by Dr. Tamara Maier opened the door for site-directed mutagenesis in
Francisella (105). These series of plasmids were the result of integrating pTOPO with
pFNL10, a native plasmid from Francisella novicida F6168 (120). This construct was
electroporated in LVS and the resulting plasmids had deletions at the fusion point
between these two original plasmids. However, these plasmids were functional shuttle
vectors between Francisella and E. coli species and were relatively stable with repeated
passage in these organisms. Dr. Karl Klose used these principles to design the pKEK887
plasmid which has a Francisella novicida FTN1451 promoter driving the erythromycin
resistance gene (94). Unlike the pFNLTP series, however, this plasmid lacks the ability
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to replicate in Francisella, making it an excellent candidate for use as a suicide vector in
targeted insertion experiments for site-directed mutagenesis. The Klose plasmid also
creates nonpolar mutations, depending on the selection of the flanking DNA around the
desired target.

Only certain antibiotic cassettes can be used in recombination

experiments in Francisella due to the nature of this organism and as a member of the
select agents of bioterrorism. The pKEK887 was used here to create a targeted insertion
of the erythromycin cassette into the capB gene of Francisella tularensis novicida U112.

Environmental factors involving encapsulation
Many different environmental factors were known to induce the biosynthesis of
encapsulation of bacteria. The PGA capsule of Staphylococcus epidermidis was induced
by increases in NaCl concentration, and this capsule helps protect S. epidermidis from
high salinity (79). In Bacillus anthracis, PGA encapsulation was induced with incubation
of the bacteria in 5 to 10% carbon dioxide. The addition of sodium bicarbonate plus
similar levels of carbon dioxide has been shown to increase PGA production in the
reengineered E. coli (6, 9). In other Bacillus species, the presence of Mg2+ or Mn2+
increases capsule production. Various methods will be attempted to try to induce PGA
capsule production in Francisella novicida.

Research objectives
The purpose of this dissertation project was to try to visualize the PGA capsule of
Francisella novicida and to identify particular external stimuli that will facilitate its
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biosynthesis. Its role in pathogenesis will also be investigated. My research has been
separated into three specific aims:

Isolate and characterize PGA mutants
Site-directed mutagenesis of the capB gene in Francisella novicida was used to ablate the
amide ligase activity of this gene’s product. A suicide vector generated by PCR SOEing
was introduced into Francisella novicida by electroporation. Loss of the transcript of
capB will be confirmed by RT-PCR and characterization assays for the loss of
encapsulation were performed.

Demonstrate potential PGA production
Immunoelectron micrographs using transmission electron microscopy was used with
antibodies specific for PGA to try to visualize the PGA capsule of Francisella novicida.
Extractions from the outer membrane were also be analyzed by mass spectrophotometry
and amino acid analysis for presence of PGA.

Determine environmental factors which may influence PGA production
Various growth conditions were examined in order to determine which may promote
PGA encapsulation of Francisella novicida. Outer membrane extractions from various
growth conditions were blotted with the same antibodies used in the immunoelectron
micrographs.
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CHAPTER TWO: MATERIALS AND METHODS

Bacterial isolates, macrophage cell line, and cultivation conditions
Francisella novicida U112 was provided by Dr. Karl Klose from University of
Texas, San Antonio. U112 was grown principally in three types of media: Trypticase
Soy Broth with 1% cysteine hydrochloride (TSB-C), Chamberlain’s defined media
(CDM), or M9 minimal media plus 1% cysteine hydrochloride, all at 37°C.

For

molecular cloning, E. coli DH5α was used for all plasmid propagation and grown at 37°C
in Luria Broth. Klebsiella pneumoniae was also grown at 37°C in Luria Broth. Bacillus
licheniformis ATCC 9945 was provided by Dr. Thomas Kozel and was grown in PGA
media at 30°C (177).
SmartSpec Plus.

Spectrophotometric measurements were made on a Bio-Rad

RAW 264.7 murine macrophages were provided by Dr. Suzanne

Barbour and were grown at 37°C with 5% CO2 in DMEM with 10% heat-inactivated
fetal bovine serum and 1mM nonessential amino acids (all media components from
Gibco-BRL).

Construction of suicide vector, pEF25
In order to create Francisella homologous DNA fragments needed for proper
recombination with the U112 genome, genomic DNA was extracted from inocula of
Francisella novicida U112 grown overnight in Trypticase Soy Broth with 1% cysteine
hydrochloride using the Epicentre DNA extraction kit. Extracted genomic DNA (100 ng)
was used as template in PCR reactions with primers listed in table 1.
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PCR was

performed using a MJ Research PTC-200 Thermocycler and using the Pfu polymerase
(Stratagene). The erthyromycin cassette of pKEK887 was used as template for the
antibiotic marker for this suicide vector. This vector has a Francisella novicida promoter
driving the erthyromycin cassette, which was essential for expression of the cassette (94).
Once all three PCR fragments were created and isolated from 1% agarose electrophoresis
by the QIAGEN gel extraction kit, these DNAs were combined together into a single
PCR SOEing reaction. The resulting fragment of ~3kb was subsequently restriction
digested with SalI and ligated using NEB T4 ligase into pBlueScript SK+ plasmid using
blue / white selection and selection for erthyromycin resistance at 100 µg/ml. Resultant
colonies were initially verified for accuracy by MW via 1% agarose electrophoresis and
additionally verified by QIAGEN plasmid prep DNA restriction with Sal I, liberating the
DNA insert from the plasmid. One was designated pEF25.

Electroporation of pEF25 into U112
1 µg of pEF25 DNA resuspended in milliQ water was mixed together with 100 µl
of thawed competent U112 in a 0.2 cm electroporation cuvette. These bacteria were
made competent after overnight growth in TSB plus 1% cysteine to an OD600 of 1.5,
washed twice in 0.5M sucrose, and frozen to –80°C. The electroporation was performed
as in Pavelka (97), at room temperature in a Bio-Rad Gene Pulser set at 2.5kV, 25 µF,
and 600 ohms. The inoculum was then placed into 1ml of TSB plus 1% cysteine for a
two hour recovery period in a shaking incubator at 37°C. The inoculum was then plated
to TSB plates with 1% cysteine and 100 µg/ml erythromycin for two days at 37°C.
18

RT-PCR / PCR for capB knockout confirmation
RNA was isolated from wildtype and mutant bacteria using the RNAeasy
QIAGEN extraction method and resuspended in DEPC-treated water. RNA was checked
for quality by spectrophotometry and 260 / 280 ratio. 2 µg of RNA was used in an
Invitrogen Thermoscript RT-PCR system to convert RNA to cDNA, utilizing the random
hexamer protocol. Subsequent Taq PCR was performed using primers from table 1 under
the following conditions: 1 cycle at 94°C for 2 min, followed by 30 cycles of 94°C for 30
seconds; 56°C for 30 seconds; 72°C for 1 min, 30 seconds; and an extension period at
72°C for 7 min.

Presence of cDNA products was confirmed via 1% agarose gel

electrophoresis.

Growth curves and growth conditions
Two hour timepoint measurements of OD600 were made for logarithmic growth
curves of bacterial cultures inoculated by normalized amounts from overnight cultures in
TSB plus 1% cysteine or Chamberlain’s defined medium (CDM). Various media were
used including supplemented 0.5M, 1M, 1.5M, and 2M NaCl; 10mM, 25mM, 50mM,
100mM, 150mM, and 200mM MgSO4; 50mM L-glutamic acid; and 10% carbon dioxide
plus 0.5 to 1% NaHCO3. Subtractive media were used as well, such as CDM without
ferrous chloride; spermidine; and M9 minimal media plus 1% cysteine and without
carbon sources. Congo Red was added to various agar media at a concentration of 100
µg/ml.
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TABLE 1
NAME
RS
UniUP
UniDN
CapCF1
Sal I
U112CapR1

PRIMER
TGCATTAGGAAGCAGCCCAGTAGT
TTCCTTTCGGGCTTTGTTAGCAGC
GATGCTGTCGACCCCATTGTCTTACATAGATAGC
ACTACTGGGCTGCTTCCTAATGCAGGAGTTGGTA
ATATTAAAGATATTGG
U112CapF2
GCTGCTAACAAAGCCCGAAAGGAACTACTGTTCT
ATATCCTCCAGC
U112CapR2 Sal I GATGCTGTCGACCAATTGCTTTATCGGCTTATGC
CapB2F
GCACAAAGCTTATCCCAAAGC
CapB2R
GCAGCTACTGTCCCTGTTGGAG
SpoT2F
TAACCATGCCGGATTAGGATCAGCA
SpoT2R
CAGTTGGAAACTCTTGCGTTTGAG
PolA2F
TGGAGGAAGTCCTAGCTTCTCGAA
PolA2R
CAGCTTGATGATCTGATTGCGGA
CapC1F
ATCCAGGTACAACCATACCAC
CapC1R
TGGATCCGTTAACGCTCTCGA
PLASMIDS
pFNL10
native plasmid from F. novicida F6168
pFNLTP
F. tularensis / E. coli shuttle plasmids derived from
integration of pTOPO and pFNL10
pFT7T
pFNLTP7 shuttle plasmid with oriT addition
pKEK887
pET15b based plasmid with FTN_1451 promoter for
Erm cassette
pEF25
pBluescript SK + plus flanking capB U112 genomic
sequences and Erm cassette
RS = restriction sites

20

Immunoelectron microscopy
Immunoelectron micrographs were created similar to the Sebastian protocol
(150). 200-mesh Formvar carbon-coated copper grids were dropped onto 8 µl drops of
bacteria for 1 min. The grids were then blocked in 0.5% fishskin gelatin in PBS with
0.1% Tween 20 for 5 min. Primary antibody diluted to 1:20 in PBS was placed onto
these grids for a 20 min incubation, then washed for 1 min in 0.1 x PBS-Tween. Gold
colloidal beads bound to Protein A were used as a secondary antibody diluted to 1:10 for
another 20 min incubation. The grids were then washed in milliQ water twice for 1 min
each. Grids were then dried overnight and visualized by a JEOL JEM-1230 TEM (70).
Primary antibodies included a F26G3 monoclonal from Dr. Thomas Kozel (80) and a
polyclonal from Dr. Rachel Schneerson (148), both against polyglutamic acid.
Preimmune sera were used as a control.

Sodium deoxycholate and serum sensitivity assays
Both of these assays were modeled from assays performed by Cowley (39).
Overnight cultures of bacteria were centrifuged down and washed twice in PBS. These
bacteria were then diluted to 105 CFU / ml and 100 µl were plated in duplicate into a 96well culture plate. 100 µl of either sodium deoxycholate at concentrations ranging from
0.005% to 5% or preimmune sera at concentrations from 1% to 30% were incubated with
the aliquoted bacteria for 45 min and 3 hours, respectively. These bacteria were then
serially diluted and plated to TSB-C plates for incubation at 37°C. CFUs were counted
and compared to controls.
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In vitro murine macrophage infection model
Our in vitro infection model using RAW 264.7 murine macrophages was similar
to the invasion protocol used by Tempel (170). 4 x 105 RAW 264.7 macrophages were
plated to a 24 well plate format and incubated overnight at 37°C in 5% CO2. The next
day, enough bacteria (determined by OD600) were grown, washed several times and
resuspended in PBS, so that infections of multiplicity of infections of 10 and 100 bacteria
per cell were added to respective tissue culture wells for infection for 1 hour. DMEM
culture media was then removed from each well and the macrophages were treated with
DMEM plus 25 µg/ml of gentamicin. In the two hour experiment, wells were rinsed with
PBS three times and then given DMEM plus 10 µg/ml of gentamicin for one hour. The
wells were then washed three times in PBS before lysis with 1 ml of milliQ water and
plating to TSB-C plates. In the 24-hour experiment, the 10 µg/ml gentamicin treatment
was maintained overnight and lysis by water treatment occurs the next day.

Outer membrane PGA extraction protocol
A sodium acetate / glacial acetic acid extraction procedure was used on Bacillus
species to isolate PGA (80). 10% sodium acetate and 1% glacial acetic acid was added to
bacterial culture and shaken for at least two hours. This bacterial mixture was then
centrifuged at 14K and passed through a .45 µm filter to separate the bacterial cells. The
supernatant was mixed with two volumes of ethanol to precipitate the PGA overnight at
4°C. The ethanol mixture was centrifuged at 12K for 30 min at 4°C and the pellet was
resolubilized in a 10% sodium acetate and 1% glacial acetic acid solution and then
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reprecipitated in two volumes of ethanol overnight at 4°C. The resulting pellet was then
dried for 10-15 min and resuspended in 1ml milliQ water.

Anthrone carbohydrate and BSA protein assays
The anthrone assay was a spectrophotometric tool to measure the monosaccharide
concentration of a solution. The assay involves the hydrolysis of oligosaccharides and
subsequent dehydration of monosaccharides (usually 400 µl of an organic solution) by 1
ml of sulfuric acid. This was mixed with 100 µl of 2% anthrone in ethyl acetate, which
reacts to form a furfural compound. These solutions were then read at A260nm after a 10
min incubation. Standards were made of increasing concentrations of glucose (84).
The BSA assay was based on the Bradford assay, which was used to measure
solubilized protein. 200 µl of an acidic solution of Coomassie Brillant Blue G-250 dye
was mixed with 800 µl of either the protein standard or sample and incubated at room
temperature for at least 5 min.

Similar spectrophotometric readings were made at

A595nm. Both of these assays were performed in duplicate.

Dot blot protocol
Three µl of extract were dropped onto strips of nitrocellulose and dried overnight.
Strips were then blocked for at least two hours in 3% BSA in TEN buffer (25mM Tris10mM EDTA-200mM NaHPO4, pH7.6).

Primary antibody was added to a final

concentration of 50 µg/ml and was slowly shaken for two hours. The primary solution
was removed and the strips were washed three times in wash buffer (Tris-buffered saline
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or TBS) for 10 min each. Alkaline phosphatase-conjugated secondary antibody at a
dilution of 1:10,000 was added and shaken for one hour. The strips were washed again
three times in wash buffer (TBS) and were then incubated in Pierce 1-StepNBP/BCIT
solution from Pierce for 30 min. The strips were dried overnight before interpretation
and analysis.

Desiccation protection model
These experiments were modeled after similar experiments performed on
Azotobacter vinelandii by Campos (23).

Francisella novicida bacteria was grown

overnight, washed and resuspended in M9 minimal media plus 1% cysteine without
carbon sources. Cell density was then measured by OD600, and normalized amounts were
then aliquoted to separate microfuge tubes, left open, and stored at 30°C in a dry
incubator. These samples were then resuspended each day in the same minimal media,
diluted, and then plated to TSB-C plates for CFU counts. Experiments proceeded for
three to four days of desiccation.

Acid resistance assays
These assays were modified from assays performed by Foster (52, 133).
Overnight cultures were subjected to lower pH during stationary phase by the addition of
drops of HCl. The pH of these cultures were measured by using pH strips and then
incubated for two and four hours, shaking at 37°C. These bacteria were then diluted at
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these timepoints and plated to TSB-C plates for CFU counting. Survival data were
extrapolated from CFU of the wildtype bacteria compared to the mutant bacteria.

Glutamate decarboxylase assay
1.8 ml of overnight cultures were centrifuged at 12K for 3 min and the pellet
washed and resuspended in 1ml PBS. The bacteria were pelleted again and vortexed
vigorously. 500 µl of GAD reagent, defined as 1 g of L-glutamic acid, 0.05 g of
bromocresol green, 90 g of NaCl, and 3 ml of Triton X-100 per liter, was added and
vortexed. The solution was incubated at 37°C for four hours, checking for color change
every hour. Assays using GAD reagent with Triton X-100 measures internal glutamate
decarboxylation, thus the α-decarboxylation of glutamate to γ-aminobutyric acid
(GABA) and carbon dioxide, a reduction reaction consuming an intercellular proton.
Assays without Triton X-100 were a measure of the ability of the glutamate-GABA
antiporter to function, thereby neutralizing the surrounding media (28, 130).

Electrospray ionization mass spectrophotometry
Dr. Connell Cunningham from Rohm and Haas, a subsidiary of Dow Chemical,
performed ESI MS without chromatography on three PGA extraction samples: one PGA
standard from Dr. Kozel of B. licheniformis, and two PGA extracts from U112 and capB
mutant, respectively, grown at 1M NaCl in Chamberlain’s defined media.
forwarded was from mass/charge ratios from 100 to over 1000.
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Data

Amino acid analysis
Amino acid analysis was performed by the Amino Acid Laboratory at the
University of California at Davis, Davis, CA. Bacterial extracts or samples were mixed
1:1 with 6% sulfosalicylic acid, which acts to deproteinize the sample, then centrifuged at
14K and filtered through a .45µm PTFE filter, adjusted to pH 2.2, and then loaded into a
Biochrom 30 amino acid analyzer for free amino acid analysis. To examine the total
amino acid profiles, the pellet and supernatant samples were dried slightly in a SpeedVac,
then transferred to 10ml ampules for hydrolyzation. Two mls of 6N HCl (containing 200
nmol/ml norleucine as an internal standard) was added, then purged with nitrogen gas for
5 min, and sealed using an open flame. The ampules were then heated at 110°C for 24
hours, cooled, and then purged again with nitrogen gas to dry. 10 ml of 0.2M lithium
citrate loading buffer was used to dissolve the samples, filtered through a 0.2 µm filter,
and loaded into the Biochrom 30 Amino acid analyzer.
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CHAPTER THREE: RESULTS OF EXPERIMENTS

Creation of the capB mutant in F. novicida U112
The flanking DNA sequences of capB used as the U112 homologous DNA
sequences for the suicide vector were approximately 980bp and 1050bp, respectively and
were PCR amplified from U112 genomic DNA using the primers CapCF1, U112 cap R1
and U112 cap F2, U112 cap R2, respectively. The erythromycin cassette from pKEK898
(approximately 1550bp) was amplified from a dilution of this plasmid using the universal
primers UniUP and UniDN as described by Liu et al (94). All three PCR fragments were
amplified using the following Pfu PCR conditions: 1 cycle at 95°C for 10 min, followed
by 30 cycles of 95°C for 60 seconds; 55°C for 80 seconds; 72°C for 3 min; and an
extension period at 72°C for 10 min. These fragments were then electrophoresed using
1% agarose at 95V and gel purified using the QIAGEN gel extraction kit, resuspending in
20 ul TE. All three fragments were placed together as template in a single Pfu PCR
SOEing reaction using the outside primers CapCF1 and U112 cap R2. The universal
sequences from the erythromycin cassette were embedded into the primers U112 cap R1
and U112 cap F2, which acted as complimentary sequences for the PCR SOEing. At
least 25ng of each PCR fragment was needed for the PCR SOEing reaction, using the
following parameters: 1 cycle at 95°C for 5 min, followed by 30 cycles of 95°C for 60
seconds; 55°C for 40 seconds; 72°C for 6 min, 30 seconds; and an extension period at
72°C for 10 min. The resulting fragment was approximately 3.2kb and once gel purified
as stated before, it was used as template in a subsequent PCR reaction with the same
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parameters as the PCR SOEing reaction. This amplified product was then gel purified
and 500 ng of this product was used in a 25 µl Sal I restriction digest to cleave off the
ends of the primer sequences. At the same time, pBluescript SK+ was propagated in a
DH5α overnight culture and plasmid DNA was acquired using the QIAGEN miniprep
kit. This plasmid was capable of blue / white selection of recombinant DNA colonies due
its genotype. Approximately 5 µg of plasmid DNA was used in a 50 µl Sal I restriction
digest and after 1% agarose electrophoresis, was gel purified and resuspended in 50 µl
TE. These two Sal I digested DNAs were mixed together in a 20 µl NEB T4 ligation
reaction using appropriate controls to determine plasmid religation efficiency and amount
of uncut plasmid in our plasmid restriction digest. Approximately 8 µl of these ligation
reactions were used in 100 µl E. coli transformation reactions, using DH5α made
competent after CaCl2 washes. The bacteria-DNA mixtures were heat shocked for 40
seconds at 42°C and then incubated at 37°C in rich SOC media for 40 minutes before
plating aliquots to LB agar Ampicillin plates at 100 µg/ml and with both X-gal (80
µg/ml) and IPTG (20mM). After several attempts using increased amounts of insert
DNA, two to three white colonies were inoculated in 2ml of LB Amp100 broth and
checked the next day via QIAGEN miniprep and 1% agarose electrophoresis. Two
clones had MW of approximately 6.2 kb. These clones were confirmed as correct
recombinants by Sal I restriction of plasmid DNA and 1% AGE, resulting in excision of
the DNA insert from the plasmid DNA. They were also confirmed by PCR of the diluted
plasmid DNA using the Liu et al. (94). universal primers to amplify the erthyromycin
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Figure 2. Method for targeted mutagenesis of the Fn capB gene, which was
predicted to encode an amide ligase. PCR SOEing was used to construct a nonpolar
ΔcapB::Erm allele, which was cloned into pBS SK+ and transformed into F. novicida
U112 with selection for erythromycin-resistant (100 mg/ml) recombinants according to
Liu et al. (94). A double recombination event was necessary for the creation of the capB
mutant, which was introduced into F. novicida U112 by electroporation.
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cassette. The bacteria were inoculated in 4 ml of LB Amp100 broth for plasmid DNA
from a miniprep, resuspending in 50 µl of milliQ water instead of TE. 1 µg of pEF25
was electroporated in F. novicida U112 made competent by washes in 0.5M sucrose. As
a positive control for electroporation, pFT7T, a derivative of the Maier shuttle plasmid
pFLNTP7 (105), was used. This plasmid has a kanamycin resistance cassette and was
known to create kanamycin resistant Francisella at 15 µg/ml. TSB-C plates with 100
µg/ml of erthyromycin were used to isolate recombinant Francisella having a double
recombination event with pEF25 (Fig. 2). Several methods were used to ensure that the
picked, erthyromycin resistant Francisella colonies were targeted insertions into our gene
of interest.
First, approximately 23 Francisella colonies grew on the experimental
electroporation plates. These colonies were patched to another TSB-C plus Erm 100
µg/ml plate as well as used to inoculate 2 ml of fresh TSB-C media at 37°C overnight.
These cultures were then centrifuged, washed with PBS twice, and resuspended in 200 µl
of PBS. 2 µl of these cultures were used as template in a Taq PCR reaction using the Liu
et al. (94) universal primers (most culture media contains ingredients which may inhibit
PCR reactions) to amplify the embedded erthyromycin cassette. Genomic U112 DNA
was used as a negative control and a dilution of pKEK887 was used as a positive PCR
control. The parameters of the PCR reaction were as follows: 1 cycle at 95°C for 7 min,
followed by 30 cycles of 95°C for 30 seconds; 55°C for 30 seconds; 72°C for 1 min, 30
seconds; and an extension period at 72°C for 7 min. Upon 1% AGE (Fig. 3), two of the
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Figure 3. Screening of the potential recombinant clones via PCR of the
erythromycin cassette. I initially screened our Erm resistant Francisella colonies by
performing PCR of the erythromycin cassette on bacterial inocula using the Uni primers
shown in table 1. This PCR product was about 1.1 kb in length. This product
demonstrated the existence of the Erm cassette in the genome of our potential mutant.
Our transformation efficiency was approximately 10%.
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23 colonies presented a ~1.5kb band which ran at the same MW as the positive control.
These colonies were termed EF98 and one was selected for the remaining experiments.
Second, genomic DNA was isolated from capB mutant EF98 using the Epicentre
DNA purification kit and this DNA was used, along with genomic DNA from U112, as
template in another Taq PCR reaction using primers CapCF1 and U112 Cap R2, with the
following parameters: 1 cycle at 95°C for 7 min, followed by 30 cycles of 95°C for 30
seconds; 60°C for 30 seconds; 72°C for 3 min, 15 seconds; and an extension period at
72°C for 7 min. When compared by 1% AGE, the PCR product for EF98 had a slightly
higher MW than the PCR product from U112 (data not shown). The difference in MW
was due to the incorporation of the larger erthyromycin cassette into the genome of our
recombinant. Additionally, these PCR products were subjected to Bgl II restriction
digests and were run on 1% AGE (Fig. 4). The FTN1451 promoter of the erthyromycin
cassette has a Bgl II site, which was lacking in the U112 sequence (94). Two bands at
1.1 and 1.8 kb were seen for capB mutant EF98, while the wildtype U112 PCR product
was uncut. This demonstrates the incorporation of this antibiotic cassette into our gene of
interest.
Third, I wanted to determine whether the transcript for capB was lost in our
recombinant clone. After overnight cultures were made, RNA was procured from capB
mutant EF98 and U112 using the QIAGEN RNAEasy kit. The 260 / 280 ratio for EF98
and U112 was 1.825 and 1.7713, respectively.

Both RNAs were measured to be

approximately 2 µg/µl and 1 µl of each was used to create cDNA utilizing the Invitrogen
RT-PCR System with the random hexamer primer protocol. A reaction for each was run
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Figure 4. Bgl II restriction of capB PCR product. Our capB mutant EF98 was
confirmed via PCR using our outermost primer set and restricting with Bgl II. The only
Bgl II site present should be the site located inside the promoter sequence of the
erythromycin cassette (94). This restriction provides evidence that our antibiotic cassette
incorporated itself at the capB locus. The product from wildtype bacteria remains uncut
at ~3kb.
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Figure 5 A and B. RT-PCR for transcriptional analyses. A) Loss of expression of the
capB transcript was shown by electrophoresis after RT-PCR using random hexamer
primers and subsequent PCR with gene specific primers (table 1). The two clones of
EF98 do not amplify the 377bp PCR fragment for capB, but do amplify transcripts for the
genes polA and spoT. A genomic DNA amplification was also shown as a positive
control. B) RT-PCR and subsequent PCR was also performed on the immediately
downstream transcript of capC, presenting our site-directed mutagenesis of capB as
nonpolar, thus attributing any changes in phenotype to the loss of capB gene function.
Negative RT controls demonstrated no DNA contamination of our RNA preparations.
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without RT as negative control for cDNA (data not shown). Specific primers for various
transcripts were used in the subsequent Taq PCR reaction, including capB, polA, spoT,
and capC (see table 1). The reaction parameters were as follows: 1 cycle at 94°C for 2
min, followed by 29 cycles of 94°C for 30 seconds; 56°C for 30 seconds; 72°C for 1 min,
30 seconds; and an extension period at 72C for 7 min. The original RNAs were run as
template as controls for potential DNA contamination. These samples were analyzed by
1.5% AGE at 95V (Fig. 5). The 822bp and 780bp PCR products for spoT and polA were
seen for both cDNAs of EF98 and U112. However, the 377bp PCR product for capB was
not seen for EF98 cDNA, but was present for U112 cDNA. Just as important, both
cDNAs amplified the downstream 99bp capC PCR product, demonstrating that the
targeted disruption of capB was nonpolar and did not affect the transcripts downstream.
No amplification was seen with the RNA samples (data not shown).

Initial phenotypic characterization of capB mutant
Initial investigation into differences between capB mutant and U112
demonstrated no differences. Both bacteria grew similarly in two hour timepoints growth
experiments to stationary phase in both TSB-C (Fig. 6) and CDM. Final overnight OD600
for TSB-C and CDM averaged 2.1 and 1.8 for both bacteria, respectively. Colony
morphology on Cysteine Heart Agar plus defibrinated blood and 1% IsoVitalex, TSB-C,
and CDM plates was the same as well, presenting as a smooth, small, opaque colony with
no change to its edges. Several experiments were performed to determine if changes to
the outer membrane by our mutant could be ascertained. Congo Red was added to 100
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Figure 6. Time course experiment of U112 vs. capB mutant EF98 in TSB-C. There
was no growth disadvantage for the capB mutant when compared to the wildtype in TSBC. Similar data were obtained for growth in CDM (data not shown). Overnight cultures
were also similar in final OD600.
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µg/ml to TSB-C plates and both bacteria were plated this agar. This dye binds to
lipoproteins on the surface of bacteria and turns bacteria various shades of red depending
on the amount of dye incorporated. This dye has been used to characterize many Oantigen mutants in gram-negative bacteria, including Francisella holarctica LVS, in
which dye was able to bind to lipoproteins normally protected by the polysaccharides of
the O-antigen. LVS colonies that normally appear pink in color contrasted with the dark
red color seen in galactosyl transferase mutants or wbtA mutants. If a PGA capsule were
providing any protection to lipoproteins on the surface, there may be a color differential
seen on these plates (91, 128). However, no change in color was seen between the
mutant and wildtype U112 (data not shown).
Variable results have been seen in experiments on F. novicida O-antigen mutants
and their sensitivity to sodium deoxycholate, a water-soluble ionic detergent commonly
used in cell lysis, liposome preparation, and isolation of membrane proteins and lipids.
Cowley et al. (39) has stated that the activity of hydrophobic antibiotics and certain
detergents against the cell membrane of gram-negative bacteria was largely influenced by
the association between LPS and other molecules of the outer membrane.

If the

equilibrium of divalent cations was upset by the loss of largely negative components of
the outer membrane, increased susceptibility to these type of detergents may result.
Cowley et al. (39) has shown that an wbtA mutant has a increased sensitivity to increasing
concentrations of sodium deoxycholate. However, Li et al. (94) has reported an increase
in resistance of an LVS galactosyl transferase mutant to sodium deoxycholate. Raynaud
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Figure 7.
Treatment of bacteria with variable concentrations of sodium
deoxycholate. Equal numbers of bacteria were subjected to treatment with 0 to 5%
sodium deoxycholate (an ionic detergent) for 45 min to disrupt the cell envelope. At
0.5%, the capB mutant was highly sensitive compared to wild-type. Sodium
deoxycholate was a water soluble ionic detergent/bile salt commonly used in applications
ranging from cell lysis (RIPA Buffer), liposome preparation, and isolation of membrane
proteins and lipids. Changes to outer membrane architecture could cause increased
sensitivity to sodium deoxycholate.
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et al. (128) has reported no difference in sodium deoxycholate sensitivity between a wbtA
mutant and wildtype LVS (39, 91, 128).
I performed similar experiments with our capB mutant to determine whether a
difference in sodium deoxycholate sensitivity could be seen. At concentrations less than
0.05%, no statistical difference could be seen between the capB mutant and wildtype
U112 (Fig. 7). However, at 0.5% and 5%, a statisticaldifference was seen in viability
between these two bacteria. At 0.5% sodium deoxycholate, up to 44% of the wildtype
U112 bacteria survived treatment while only 1% of the capB mutant bacteria survived
(p=.0002). At 5% sodium deoxycholate, 18% of wildtype survived compared to 1% of
the capB mutant (p<.0001).

These results suggest an ionic difference at the outer

membrane of the capB mutant, which may be the loss of a polyanionic barrier helping to
stabilize the integrity of the outer membrane.

Serum sensitivity assays and in vitro macrophage infection studies
Another set of experiments performed to determine changes made to the outer
membrane include preimmune serum sensitivity experiments. Preimmune serum has
bactericidal properties due to the complement proteins it contains, which ultimately leads
to formation of the MAC complex and cell lysis. The formation and deposition of
complement proteins has been shown to occur more readily in the absence of O-antigen
chains, which cover the lipid A determinants recognized by complement.

This

phenomenon involves both the classic and alternative complement pathways (158).
Sandstrom et al. (140) described a capsule-deficient Francisella LVS and its
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susceptibility to serum treatment. This killing by serum was ablated by heat-inactivation
of the serum, demonstrating that complement was directly involved. These mutants,
however, were created via chemical mutagenesis (acridine orange), were not genetically
verified, and were termed capsule mutants due to their rough morphology (140). It is
likely that these capsule mutants were actually LPS mutants, due to the familiar
phenotype seen in LPS mutant serum experiments. It was believed that in the case of
several PGA producing bacteria that loss of encapsulation may allow increased
deposition of complement proteins as well. To test whether our mutant would have
limited viability in preimmune serum, I incubated normalized amounts of bacteria, after
being washed in PBS, with increasing amounts of preimmune rabbit serum, to final
concentrations of 1, 2.5, 5, 10, 20, and 30%. After treating cells for three hours in a 96well format in duplicate, 100 µl aliquots were diluted in PBS and plated to TSB-C plates
for measurement of CFUs. Mean counts for CFUs for these experiments ranged from
16.5 to 63, and although there were experiments at median serum concentrations which
demonstrated a statistical difference between U112 and capB, our counts for capB were
lower than wildtype and there was no significant decrease in CFU as serum
concentrations increased (Fig. 8). One would expect reduced viability of both bacteria
with increased serum, yet this was not seen.
Several characterizations of capB mutants in Francisella have shown a decrease
in virulence in animal infection models, which has been attributed to attenuated
pathogenesis due to reduced bacterial burden in macrophages and other target cells and
reduced dissemination. Su et al. (161) presented a substantial reduction in virulence of
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Figure 8. No statistical significant difference between bacteria treated with
preimmune serum. Our studies seem to indicate that our capB do not fare as well as
their wildtype counterpart against blocking the effects of complement. However, no
statistical significant difference was seen at any concentration of serum, as increases in
serum treatment did not demonstrate reduction in number of CFUs.
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both transposon and direct mutagenesis of capB compared to wildtype in intranasal LVSinfected BALB/c mice. In these co-infection experiments, only the wildtype bacteria
were isolated from the organs of infected mice in these 1:1 ratio infections.

The

attenuation was corrected via complementation with the capB gene. Singular murine
infection experiments with the mutant only were performed as well, compared to mice
infected only with LVS. These mutant infections presented a 1,000 fold reduction in
bacterial burden of the lungs (161). A negative selection screen by Weiss et al. (186) of
F. novicida transposon mutants also elucidated capB as encoding a potential virulence
factor for Francisella. Genomic DNA from the transposon input bacteria was collected
as well as DNA collected from the bacteria in the spleens after 48 hours of intraperitoneal
infection.

These DNAs were used to probe a Francisella microarray, which

demonstrated an absence of the capB mutant bacteria DNA in the infected spleens (186).
Several other discovered infection-attenuated mutants were subjected to in vitro
macrophage infection models, in which bone-marrow derived macrophages were used.
Two groups of mutants were determined, one having reduced intracellular growth
capability and the other which replicated just as the wildtype. The capB mutant was not
one of the bacteria selected for these experiments.
I infected RAW 264.7 murine macrophages in a 24-well format with both our
U112 wildtype bacteria and the capB mutant. 4 x 105 macrophages were plated per well
and enough bacteria to provide both a multiplicity of infection (MOI) of 10 and 100 were
used. The bacteria were added for an infection period of one hour, then were either
incubated for an additional hour or 24 hours. Extracellular bacteria were then eliminated
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Figure 9. Macrophage infection model (2hr) demonstrates no potential entry
differences between U112 and capB. Murine macrophage cell line RAW 264.7 were
plated and infected with F. novicida for 1 hr, after which the cells were washed in
gentamicin (25 mg/ml) for an additional hour, washed with PBS, then lysed with milliQ
water before plating onto TSB-C plates. At both MOIs of infection, there were no
significant differences in the number of the capB bacteria compared to WT.
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Figure 10. Macrophage infection model (24hr) demonstrates replicative potential
differences between U112 and capB. As for the replicative capacity data, at both MOIs,
capB show a decrease in replication inside the RAW 264.7 macrophages when compared
to the wildtype U112.
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with gentamicin washes. Infected cells were lysed with water and plated to TSB-C plates
for CFU counts. No difference was seen at the lower MOI at two hours nor at the higher
MOI at two hours, indicating no statistical difference in entry between the two bacteria
types (Fig. 9, 10). At 24 hours, both MOIs demonstrated approximately a 1.5 log
increase in CFUs between the wildtype U112 and capB (p<.01). This data suggests that
the capB mutant has a reduced intracellular growth capability in macrophages.

Attempted visualization of the PGA capsule of Francisella
There were several methods which can used to visualize the capsule of
encapsulated bacteria. In certain bacteria which elicit a relatively large capsule, such as
Streptococcus pneumoniae or Kiebsiella pneumoniae, the capsule can be visualized using
a light microscope and particular stains. The PGA capsule of Bacillus, for instance, can
be visualized using nigrosin in wet or dry mount preparations. This was due to two
important factors: the size of the bacterium and the size of its capsule. Most Bacillus
species were rather large (1-2 micron), and the capsule appears as a halo around the
bacteria. Due to the relatively small size of Francisella (.2 to .4 micron), I had a difficult
time using these types of techniques to even visualize the polysaccharide capsule.
Although there appeared to be a halo around our wet and dry preparations of Francisella
which were grown in repeated passages of CDM, these images were not conclusive of
encapsulated bacteria (data not shown). These images also were unable to ascertain the
difference between a polysaccharide capsule and one made of PGA.

In order to

specifically visualize a PGA capsule in Francisella, antibodies specific to PGA were
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needed for use in immunoelectron microscopy studies.

F26G3 was a monoclonal

antibody against the PGA of B. licheniformis, which has been shown to cross-react with
PGA from B. anthracis (81). I also obtained a polyclonal antibody against B. pumilus,
which reacts with PGA made by Staphylococcus epidermidis (79, 80, 81). One problem,
however, was that no experimentation has been performed to determine the limit of
crossreactivity amongst antibodies to PGA and different polymers of PGA (see Fig. 1).
Initially, I used a mounted immunoelectron technique, which has been used to
visualize Kiebsiella pneumoniae and its capsule. After both wildtype U112 and capB
mutant were grown in CDM, these bacteria were washed in PBS and resuspended in
antisera. These samples were then fixed in 5% glutaraldehyde-0.1 M sodium cacodylate
buffer (pH 7.3) with 0.15% ruthenium red. Following several washes with this same
buffer but with 0.05% ruthenium red, cells were fixed for one hour in 2% osmium
tetroxide with 0.05% ruthenium red. The bacteria were again washed in this buffer with
0.05% ruthenium red and embedded in 2% agar before dehydration with increasing
acetone solutions and embedding in Spurr's plastic (116). Ultrathin sections were cut and
placed upon Formvar grids for inspection on a JEOL JEM 1230. Although this process
was able to provide fair images of the embedded bacteria, the blade of the ultratome
would push the bacteria in and out of the matrix, not slicing the bacteria as cross sections.
Although other bacterial capsules have been seen using this technique, it seemed that the
capsule of Francisella was fairly loosely associated and would not withstand such harsh
treatment. It was determined that using a whole mount technique would enhance our
chances for this visualization.
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I then attempted to use a 1% phosphotungstic acid to negatively stain whole
mounts of bacteria after incubating in CDM. While this process provided nice images of
the bacteria capsule, it was not an immunoprocedure in which I could use antibodies to
differentiate between types of capsule being produced. Sebastian et al. (150), in his
immunoelectron micrographs of LVS O-antigen mutants, cited the procedure performed
by Huebner et al. (70) in their characterization of capsular polysaccharide antigen of
Enterococcus faecalis and E. faecium. This procedure did not require any negative
staining of the whole mounted bacteria, and utilizes antibodies so that specific
identification of components of the bacterial capsule can be made.

Empiric

determination of the primary antibody dilution was made and a 1:20 dilution in PBS
proved effective. Visualization of reacting antibodies was made with Protein A gold
colloidal particles at 10nm. Several milliQ water washes were necessary at the end of the
procedure to avoid “salting out” on the grids, which occurs when the PBS from the
antisera was not adequately removed and dries into a salt film with covers the grids,
making analysis much more difficult (70).
Immunoelectron micrographs were obtained of the wildtype U112 and the capB
mutant when grown in standard media of TBS-C or CDM following treatment with the
F2G63 monoclonal antibody, and this demonstrated gold particles either at the periphery
of both bacterial strains or in diffuse material outside attached to the Formvar grids (data
not shown). The experiments with the polyclonal antibody also did not seem specific to
any material on the grids (data not shown). Capsular material was seen, primarily in the
CDM preparations, but there was no difference in specificity observed with the
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antibodies when comparing the U112 and capB samples. Images of bacteria subjected to
various environmental conditions will be discussed later.
Positive control immunoelectron micrographs were performed on B. licheniformis
grown in PGA medium at 30°C with shaking at a lower RPM of 200. These bacteria
were treated with both the F26G3 monoclonal and the B. pumilus polyclonal. These
images revealed diffuse material surrounding most of the gram-positive bacteria seen,
and the secondary gold particles demonstrated association with this diffuse material in
equal density as that seen in our experimental grids (Fig. 11). This association was more
prominent with the monoclonal than with the polyclonal, as with the experimental grids.

Outer membrane extraction for PGA
For more definitive analyses to be performed on the capsule of Francisella, an
appropriate capsule extraction method was needed in order to perform both biochemical
and immunological analyses. In earlier times, capsule extraction for the polysaccharide
component of Francisella required medium concentration NaCl washes from cultures, as
was performed by Hood (68). Detergents, such as dilutions of cetavalon or Zwittergent
3-14, have been used to strip off the outer layer of bacteria for analysis of the capsule
(45). Many other methods have been described as well, ranging from Waring blender use
to sonication. To complicate matters, I was looking for a PGA extraction procedure for a
gram-negative bacteria, as most of the gram-positive bacterial extraction procedures I
researched included harsher techniques. Initially, I tried extracting the capsule from
bacterial cultures using both the agitation of autoclaved glass beads and 10mM EDTA,
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Figure 11 A and B.
Positive control immunoelectron micrographs of B.
licheniformis with antibody against PGA. B. licheniformis was grown with reduced
agitation at 30°C for several days until turbid cultures were seen. Cultures were placed
onto Formvar grids and treated with A) F26G3 monoclonal against B. licheniformis or B)
polyclonal against B. pumilus from Dr. Rachel Schneerson. In both cases, the antibodies
were visualized by secondary gold colloidal particles (10nm) bound to Protein A.
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respectively. These procedures were very harsh and resulted in crude extracts which
required additional enzymatic treatments and had inconsistent initial results with both the
Bradford assay and the anthrone assay, which measure protein and simple sugar
concentrations, respectively. Several protocols were then attempted, including use of
detergents, such as cetavalon and zwittergent 3-14; and PGA extraction procedures
against Bacillus anthracis from both Chabot et al. (29) and Kozel et al. (80). Most of
these included two to three ethanol precipitations, as both polysaccharide and PGA
polymers can be precipitated similarly.

The Chabot et al. protocol (29) called for

treatment of the bacterial supernatant with a nuclease in buffer containing 0.1M Tris,
10mM MgCl2, 0.1M NaCl, and 0.02% sodium azide. It also requires a 5% trichloroacetic
acid precipitation, which can be used in both protein and nucleic acid precipitations,
depending on the concentration. I, however, proceeded to use the Kozel et al. (80)
technique as this procedure incorporates the supernatant of the culture as well as washes
from the bacteria. It requires washes with 10% sodium acetate and 1% glacial acetic
acid, as well as two ethanol precipitations. These extractions were used in many different
assays to determine potential PGA levels, but initially, anthrone and BSA assays were
performed to uncover their biochemical nature. Extract from U112 grown in CDM
produces approximately 8 µg/ml and 2.46 µg/ml of glucose equivalent and BSA
equivalent, respectively. CDM media itself has at least 3.9 mg/ml of glucose and BSA
results of fresh media usually were <0.2 µg/ml.
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Differences in bacterial growth
It has been shown that PGA was capable of protecting several bacteria during
growth in high salt conditions (71). Most neutralophiles can tolerate salt concentrations
up to 2M NaCl, whereas at higher concentrations, the loss of intracellular water, thus
turgor pressure, causes plasmolysis (21). Staphylococcus epidermidis was one of the best
known bacteria in which PGA protects this organism due to its high salt environment, the
human skin.

It has been shown that capB mutants in S. epidermidis not only

downregulate capB expression in periods of high salt (2M NaCl), but also have a growth
disadvantage when compared to wildtype (79).

Similar growth experiments were

performed with our capB mutant in comparison with its wildtype control. Overnight
growth in both TSB-C and CDM with incremental increases in NaCl concentration
(0.1M, 0.5M, 1M, and 2M) were made. These cultures were started from aliquots of
overnight cultures in their respective media into test tubes with 3ml of fresh media plus
the NaCl addition. There were statistical differences in final OD600 readings in our TSBC experiments at 1M and 2M concentrations (p<0.05 and p<0.001, respectively), in
which the wildtype U112 outgrew the capB mutant (Fig. 12, 13). Similar data was
obtained in our CDM experiments, in which the U112 growth advantage was more
apparent at 1M (p<0.05). It also seemed that both strains better tolerated with the higher
salt concentrations in TSB-C than in CDM (at 1M NaCl, OD600 range of 1.4 to 1.7 vs. 0.5
to 0.7). This was probably due to the fact that CDM has approximately double the
amount of NaCl as TSB-C (9.9g per liter in CDM vs. 5g per liter in TSB-C).
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Figure 12 A and B. Differences seen in growth cultures in TSB-C when grown at
NaCl concentrations greater than 1M. A) When grown in TSB-C, the capB mutant
showed significant reduction in growth when compared to wildtype U112 at both 1M and
2M NaCl concentrations for overnight inoculations. B) The time course experiment
performed at 1M NaCl in TSB-C demonstrated a significant difference in growth at late
log phase between the capB mutant and the wildtype U112.
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Figure 13 A and B. Differences seen in growth cultures when grown in CDM at
NaCl concentrations at 1M. A) In the synthetic media CDM, the capB mutant also
showed significant reduction in growth when compared to wildtype at both 0.5M and 1M
NaCl concentrations for overnight inoculations. B) The time course demonstrates a
significant difference in OD600 at growth points during log phase when grown in CDM
plus 1M NaCl.
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These growth advantages of U112 over the capB mutant were also demonstrated
in time course experiments, which demonstrated the growth differential between U112
and capB. OD600 readings between the two bacteria, grown in TSB-C plus 1M NaCl, did
not show a statistical difference in growth until twelve hours after inoculation, whereas
there was a statistical difference seen at an earlier timepoint (six hours) with growth in
CDM plus 1M NaCl. Again, this difference attributed to the higher NaCl concentration
in CDM. All of this data suggest that this growth advantage imparted by functional capB
may aid in Francisella’s persistence in harsh, external environments, such as the skin of
animals.
Another growth condition tested was the absence of ferrous iron in CDM. There
have been many experiments performed which show that iron was essential for growth as
well as intracellular growth and that many bacteria have evolved various tools to confront
this problem.

Sullivan et al. (162) has described how siderophores are used by

Francisella in its acquistion of inorganic iron. These iron-siderophore complexes were
then bound to receptors at the cell surface, and taken up by the organism. It has been
suggested that in other species, PGA, like other anionic polymers, acts to sequester
cations as a protective mechanism against certain metal toxins (110). It was also well
known that under iron-restricted conditions, Francisella tends to upregulate genes needed
for intracellular survival, such as the genes of the pathogenicity islands as well as
regulators (86, 115). As far as the cap operon was concerned, capD, which encodes a γglutamyltranspeptidase, has been shown to have a decreased protein level in a LVS irondeficient model (90). However, Deng et al. (42) have shown via microarray experiments
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Figure 14 A and B. Reduction in growth of the capB mutant when grown without
ferrous iron. A) Shown was a growth reduction of capB compared to wildtype when
grown in CDM without iron for overnight culture. B) A significant difference was seen
in the mid to late log phase of growth. Therefore iron restriction has an effect on a capB
mutant. It has been suggested that low Fe2+ containing environments may act as a signal
to increase virulence factors needed for intracellular survival (known increase in
expression of pathogenicity island genes). The reverse being that high Fe2+ environments
may signal adaptation to extracellular environments ie.(potentially encapsulating).
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of LVS in iron-restricted media, that capD undergoes an increase in expression (1.595
mean comparative expression level of iron-replete / iron-deplete conditions, n=7). Their
data also demonstrates reduced expression of capB in LVS in iron-restricted media (.749
mean comparative expression level of iron-replete / iron-depleted conditions, n=7). Deng
et al. (42) also showed similar expression levels of genes thought to belong to this
operon, suggesting a common mode of regulation.

Our iron-depleted CDM media

experiments demonstrated a slight growth advantage by U112 when compared to our
capB mutant in our overnight growth curve (mean OD600 of 1.260 for U112 vs. 1.156 for
capB, p<0.05) (Fig. 14). This statistical difference was seen at hour six during the
logarithmic phase of growth and throughout until stationary phase was achieved, p<0.05).
These data suggest that Francisella may, amongst other external stimuli, use free iron
concentrations as a molecular signal for intracellular vs. environmental growth.
Magnesium concentration has been shown to affect PGA production in several of
the Bacillus species. It was thought that magnesium was required by the ATPase activity
in the amide ligase reaction (6, 25). The usual range of magnesium seen to increase PGA
production in B. anthracis was 0.05% to 1%. Overnight cultures from both U112 and the
capB mutant were used as inocula to initiate new overnight cultures with increasing
concentrations of MgCl2 as well as MgSO4, respectively. One µl of culture was used to
inoculate 2 ml of CDM plus additions of the Mg salt solutions. The MgCl2 and MgSO4
concentrations tested were .5, 1, 5, 10, 25, 50, 100, 150, and 200 mM. There was no
inhibition of growth seen with either strain at the high concentrations (data not shown).
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There also was no statistical difference in stationary growth measured by final OD600
between the wildtype U112 and the capB mutant at any of these concentrations.
Another factor that has been demonstrated to influence PGA production in B.
anthracis was aerobic growth at 37°C with 5% CO2 and 0.8% NaHCO3. It was believed
that the CO2 levels indirectly influence the promoter region for transcription of the cap
operon in B.anthracis (6, 106). The genetic element recognized as well as the proteomic
entities involved were not known. Sodium bicarbonate, however, acts as a buffer to the
increase in pH due to CO2. CO2 reacts with water to become bicarbonate and a proton,
which acts to lower the pH of the media.

However, increasing the bicarbonate

concentration forces the reaction in the opposite direction, increasing the pH of the media
until equilibria was reached (106). Overnight cultures of both U112 and the capB mutant
in CDM were again used as inocula to prepare cultures grown in 10% CO2 with 0.5 and
1% additions of sodium bicarbonate for incubation overnight. There was a decrease in
overall growth of both bacteria as the concentration of sodium bicarbonate increased
(1.938, 1.670, and 1.119: mean growth of both bacteria at NaHCO3 of 0%, 0.5%, and
1%). However, there was no statistical difference seen in the final OD600 of these two
strains. As expected, I observed an increase in pH in both bacterial cultures as level of
bicarbonate increased, with a slight difference in pH between U112 and the capB mutant.
The wildtype U112 consistently had a 0.5 pH increase when compared to its capB
mutant, at all levels of sodium bicarbonate (table 2), using pH strips with a range from 2
to 9.
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Figure 15 A and B. The effects of 10% CO2 and variable concentrations of NaHCO3
on wildtype U112 and capB mutant. A) As concentrations of NaHCO3 increased in
these overnight cultures in CDM at 10% CO2, a reduction in growth of both strains was
observed. No significant difference between wildtype U112 and capB mutant was seen
until 1% NaHCO3. B) The pH readings in the culture after overnight growth under these
conditions are shown. It was consistently observed that the capB mutant had a reduced
pH when compared to U112. Both data indicate that optimal growth of these bacteria
takes place at pH < 7.
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Immunodot blot analysis for PGA
Dot blots were screened using both the monoclonal F26G3 and the polyclonal
antibody against PGA from B. pumilus, which were obtained as gifts. Extracts from both
wildtype U112 and the capB mutant grown in various environmental conditions were
placed onto nitrocellulose and dried overnight. These blots were blocked with 3% BSA
and incubated with each antibody separately in TEN buffer at 50 µg/ml and then
incubated with secondary alkaline phosphatase-conjugated antibody for visualization via
NBT/BCIP substrate. It has been shown that the F26G3 antibody reacts with the PGA
polymer from B. anthracis, which was in the D-form, as well as the D+L form of B.
licheniformis. The polyclonal against B. pumilus has been shown to react with PGA
made from B. pumilus (D+L) and the PGA made from S. epidermidis (D+L) (79).
Control blots were performed in which extractions on B. licheniformis and B. subtilis
cultures grown in PGA expression medium overnight. PGA provided by Dr. Kozel acted
as a positive control, as this PGA was extracted using the same procedure. The F26G3
antibody reacted with our B. licheniformis extraction and the positive control, but did not
react with our B. subtilis extraction (Fig. 16). The polyclonal had strong reactions with
both the positive control and the B. licheniformis extraction, and had a substantial
reaction with our B. subtilis extract. To demonstrate specificity of these antibodies to the
polymer, an additional control was performed in which aliquots of 25mM and 250mM Lglutamic acid were blotted and screened.

There was no reaction seen at either

concentration with the monoclonal.
U112 and the capB mutant were grown in CDM at 1M NaCl and 50 mM MgCl2,
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Figure 16 A and B. Control immunodot blots with PGA extracts from Bacillus
species and increasing concentrations of L-glutamic acid. A) To test whether the OM
extraction procedure was efficient, extractions were performed on several Bacillus
species (Bl = B. licheniformis, Bs = B. subtilis, Kozel Bl = PGA of B. licheniformis from
Dr. Kozel). These extracts were probed with both F26G3 and the Schneerson polyclonal.
The F26G3 recognized our Bl extract but not our Bs extract. The polyclonal recognized
both Bl and Bs extracts. Both antibodies recognized the positive control from Dr. Kozel.
B) To further test the specificity of these antibodies for PGA and not singular L-glutamic
acid, I tested both 25 and 250mM L-glutamic acid solutions against both F26G3 and the
polyclonal. No significant signal was seen for these concentrations.
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Figure 17. Immunodot blots of PGA extracts of U112 and the capB mutant grown
in CDM plus 1M NaCl and 50mM MgSO4. For the F26G3 blots, no significant signal
was seen for both the capB mutant and the wildtype U112 under both conditions. Using
the polyclonal, signals were seen for both capB and U112 at both conditions. There was
no differential seen between the mutant and our wildtype extracts.
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extracted and blotted (Fig. 17). The monoclonal and the polyclonal reacted well with the
positive control. The F26G3 monoclonal only reacted with the Bacillus positive control
at both conditions. The polyclonal antibody reacted well with the positive control, but
only faintly with the wildtype U112 and the capB mutant. The signals were of equal
intensity between the wildtype U112 and capB mutant, suggesting just background
reactivity. Control immunodot blot experiments were also run using this same antibody
on S. epidermidis and its capB mutant, which demonstrated no reaction at all with the
mutant, but positive for the wildtype (data not shown). The next set of experiments were
both the extractions and the supernatants collected after growth of both bacteria in CDM
at 10% CO2 and .5 to 1% of NaHCO3. Again, no reaction was seen at all with the
monoclonal except for the positive controls (Fig. 18). The polyclonal reacted with both
the U112 and the capB mutant with equal intensity at these conditions as well, presenting
nonspecificity. There was an increase in intensity of the signals for the experimental
extractions in the supernatant blot from 0.5% to 1% NaHCO3.

The next set of

experiments involved bacteria grown overnight in TSB-C and then subjected to a low pH
(pH 4) for one hour prior to extraction. An additional experiment was performed in
which bacteria, after the pH4 treatment, were centrifuged and lysed in a 2% SDS, 30%
glycerol, 250mM Tris hydroxyaminomethane buffer and blotted.

This lysis was

performed to determine whether our gram-positive extraction perhaps was effective in
processing PGA from our bacteria. Similarly, these samples did not react with the
monoclonal, and both U112 and the capB mutant samples reacted weakly and equally
when screened with the polyclonal antibody (Fig. 19). Thus our data suggests that none
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Figure 18 A and B. Immunodot blots for PGA in extracts and culture supernatants
of U112 and the capB mutant grown in CDM at 10% CO2 with variable
concentrations of NaHCO3. A) Extracts from the strains grown in CDM at 10% CO2
were probed with both antibodies. No signal was seen for capB mutant or the wildtype
U112 at both NaHCO3 concentrations with F26G3. There was no differential between
these two bacteria when probed with the polyclonal antibody at both NaHCO3
concentrations. B) The supernatants from these same cultures were also probed with
anti-PGA, yet demonstrated similar results at both NaHCO3 concentrations.
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Figure 19 A and B. Immunodot blots for PGA in extracts from U112 and the capB
mutant grown in TSB-C, then treated for one hour at pH4, and SDS lysates under
the same conditions. A) The extracts from both strains did not react with F26G3, and
there was no differential seen comparing the capB mutant to the wildtype U112 with the
polyclonal. B) The SDS lysates were performed in case our extraction procedure was not
extracting PGA. Again, no signal was seen from both strains with F26G3 and there was
no differential seen between the bacteria with the polyclonal.
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of the above conditions promoted the production of PGA that could be detected
immunologically.

Immunoelectron micrographs of various environmental conditions
Treatment of several PGA-producing bacteria such as S. epidermidis and S.
haemolyticus with high concentrations of NaCl has induced PGA production (49 ,79). As
I have seen growth differences between our bacteria at 1M NaCl, I chose this condition to
test for production of PGA via immunoelectron microscopy. Both strains were grown in
TSB-C supplemented to 1M NaCl for overnight culture. Using the described procedure
for creating immunoelectron grids, I observed these bacteria using both F26G3 and the
Schneerson polyclonal. Although there appears to be gold particles surrounding bacteria
of our wildtype U112, similar particles were seen on the mutant grids as well (Fig. 20).
Images with the Schneerson polyclonal were also not conclusive, with similar numbers of
immuno-gold particles seen and without specificity to the surfaces of the strains (data not
shown).
One of the environmental conditions I analyzed was treatment of overnight
cultures in TSB-C with HCl. These cultures were acidified to pH 4 to 4.5 after overnight
incubation, and shaken for an additional hour prior to addition to the Formvar grids.
Samples performed at pHs lower than 3 resulted in degradation and lysis of bacteria,
irrespective of genetic background (17). One observation at the lower pH was the level
of aggregation by both bacteria (Fig. 21).

Secondary gold particles were located

throughout the grid on the polyclonal preparations for both bacteria, with seemingly
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Figure 20 A and B. Electron micrographs of U112 and capB grown in CDM at 1M
NaCl. Electron micrographs of A) wild-type F. tularensis U112 and B) the capB mutant
grown at 1M NaCl treated with monoclonal antibody F26G3 followed by gold colloidal
10 nm particles attached to protein A. Both images demonstrate no differential of gold
particles between the two bacteria. Images were taken at 10,000x on a Jeol JEM-1230
TEM microscope.
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Figure 21 A and B. Immunoelectron micrographs of U112 and the capB mutant at
pH4 and in M9 minimal media. Immunoelectron micrographs of wild-type F.
tularensis U112 and the capB mutant treated with monoclonal antibody F26G3 A) grown
in TSB-C, then treated at pH4 and B) grown in TSB-C, then resuspended in M9 minimal
media plus 1% cysteine. While no differential was apparent in the reduced pH images
between the bacteria, there may be more gold particles in the M9 media image of U112
when compared to its mutant. Images were taken at 10,000x on a Jeol JEM-1230 TEM
microscope.
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similar uniformity. There were beads seen on the bacteria, but just as many beads were
located on the matrix itself.

It appears that the polyclonal lacked specificity for

Francisella as there were no concentrated areas seen. The F26G3 monoclonal was
localized to diffuse material either on the bacteria or on the matrix, however, the
secondary beads recognizing this antibody were seen both on the U112 wildtype preps as
well as on the capB preps, and in equal number.
Resuspension of our bacteria in M9 minimal media plus 1% cysteine after
overnight growth in rich TSB-C media was used as a starvation-stress response to see if
PGA production may be induced under these stringent conditions. Two ml of overnight
cultures were centrifuged at 12K, the supernatant decanted, and resuspended in M9
minimal media with incubation at 37°C for four hours prior to deposition on the Formvar
grids. Our analysis of these grids (Fig. 21B) showed less diffuse material on the capB
mutant grids compared to U112, but the location of secondary gold particles from F26G3
anti-PGA was not specific for wildtype. On the capB mutant grids, these gold particles
were disseminated throughout and did not associate with this material, very similar to the
pattern seen in past grid analyses with the polyclonal.

Desiccation assays
It has been shown that Azotobacter vinelandii creates an alginate encystment
when placed into a minimal medium with limited carbon sources (23). This aids in the
bacteria’s persistence in harsh conditions.

Persistence of Francisella in similar

environments was known to occur (e.g. due to infections from contact with animal
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Figure 22 A and B. Desiccation resistance test. Overnight cultures of U112 and the
capB mutant were washed and resuspended in M9 minimal media with 1% cysteine,
lacking carbon sources. Bacteria (10 µl) were transferred to tubes and incubated open in
a dry 30°C incubator. Each day, tubes were resuspended in minimal M9 media, diluted,
and plated on to TSB-C plates. A) There was a significant reduction in CFU formed by
the capB mutant when compared to wild-type control (Day one shown). B) These
numbers were tabulated and it was shown that there was a significant difference between
these bacteria on day one and two of desiccation, while no colonies were seen with either
strain after three days.
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carcasses that have been dormant for some time), although Francisella neither encysts
nor sporulates (123, 155). To test the role of capB in desiccation resistance, the U112
wildtype and the capB mutant were grown overnight in TSB-C media, centrifuged and
decanted, and resuspended in M9 minimal media plus 1% cysteine without carbon
sources. 10 µl aliquots were then placed into separate microfuge tubes and incubated in a
dry 30°C incubator. At 24-hour intervals, an aliquot would be resuspended in the same
M9 minimal media, diluted, and plated to TSB-C plates.

These plates were then

incubated for CFU counts (Fig. 22). Our results demonstrated that after one day of
incubation, the U112 wildtype bacteria were very sensitive to desiccation with a drop of
several logs in CFU. However, it was substantially more resistant than the capB mutant
(mean CFUs 1495 for U112 vs. 682.5 for capB, p<0.05). By the second day, U112 still
had some viability while the capB mutant showed no CFUs (mean CFUs 72.5 for U112
vs. 0 for capB, p<0.01). No colonies were seen on the third day for either bacteria at the
10-8 dilution.

The data demonstrated that the capB mutant was less resistant to

desiccation than the wildtype.

Acid resistance assays
Due to the environmental advantage seen with the wildtype U112 compared to the
capB mutant, we next compared their acid tolerance and resistance. The definition of
several of these terms regarding acid resistance have been confused, even amongst the
researchers who have dedicated many years to the study of the mechanisms by which
bacteria use to manipulate extracellular and intracellular pH. Acid tolerance was used to
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describe mechanisms used by bacteria to grow in acidic conditions whereas acid
resistance refers to mechanisms by which bacteria survive in acidic conditions. Acid
resistance and tolerance also applies to exposure to fatty acids as well as fermentative
acids due to metabolism (17, 28, 38). There were several systems utilized by bacteria,
and some of these were dependent on the stage of bacterial growth. Most neutralophiles
fare well in a media pH range of 6 to 8. These acid resistance experiments were modeled
after similar experiments performed by the Foster lab in which CFUs were counted after
acid treatment (133).
Francisella strains were grown overnight in either CDM or TSB-C and then
normalized aliquots were placed into their respective media that had been acidified to pH
4 by drops of HCl. These inocula were then measured by OD600 and placed in the
incubator at 37°C with shaking. At timepoints two hours and four hours, aliquots from
the inocula were removed, measured by OD600 and plated to TSB-C plates for CFU
counting. A statistical advantage was seen in the number of CFUs from U112 when
compared to the capB mutant at both timepoints in the TSB-C experiments (at two hr:
mean CFUs for U112 was 352.5 vs. 14 for capB, p<0.05; at four hr: mean CFUs for
U112 was 84.5 vs. 21 for capB, p<0.001). I also observed a corresponding difference in
the means of OD600 from the initial inocula reading to the inocula reading at the
respective timepoint. The difference in means were as follows: 0.0005 vs. 0.0145 at 2
hours for U112 and capB, respectively and 0.008 vs. 0.059 at 4 hours for U112 and capB,
respectively. The percentage of survival of the capB mutant when compared to the U112
wildtype control was 4% at 2 hours and 24.9% at 4 hours. Similar data was collected in
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Figure 23 A and B. Acid resistance test. Overnight cultures of U112 and the capB
mutant were then incubated A) two or four hours (data not shown) in TSB-C medium
adjusted to pH 4, diluted and plated onto TSB-C plates. A dramatic reduction in the
viability of the capB mutant was observed after each period of incubation at low pH. B)
Survival plots of these data were charted under the same conditions, using overnight
cultures of U112 and the capB mutant grown in CDM. The survival of the capB mutant
was 44% of control at two hours and 26% of control at four hours.
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Figure 24 A and B. Graphical representation of acid resistance data. Overnight
cultures of U112 and the capB mutant were incubated two or four hours in A) TSB-C
medium adjusted to pH 4, or B) CDM medium adjusted to pH 4. The bacteria were then
diluted and plated on to TSB-C plates. Significant reductions in the viability of the capB
mutant were observed at this low pH in both TSB-C and CDM media.

95

96

the same experiment except the bacteria were grown in CDM. The number of CFUs for
U112 was 675 vs. 300 for capB at the two-hour timepoint (p<0.05) and 913 for U112 vs.
237 for capB at the four-hour timepoint (p<0.05). The difference in means were as
follows: -0.0025 vs. 0.036 at two hours for U112 and capB, respectively and -0.005 vs.
0.0025 at four hours for U112 and capB, respectively. The percentage of survival of the
capB mutant when compared to the U112 wildtype control was 44% at two hours and
26% at four hours. For both experiments, there was little evidence of any change in pH
of the media after both timepoints.
A very similar experiment was performed in which overnight culture in TSB-C
was used to inoculate fresh media for three hours. These new cultures in log phase were
then measured by OD600 and then used to inoculate media which was acidified to pH 4.
These bacteria were then incubated like the past experiment for two and four hour
timepoints, shaking at 37°C (28). When plated after the timepoints onto TSB-C plates,
no CFUs were seen for either strain at the same dilution. These data suggest that U112
has an acid resistance mechanism (i.e., survival in acid) which was lacking or inhibited in
the capB mutant, but this phenomena was only observed after stationary growth by these
bacteria. Similar experiments performed with the bacteria in logarithmic growth suggest
that Francisella novicida U112 may not have an acid tolerance mechanism (i.e., growth
in acid) (data not shown).

Intracellular and extracellular glutamate decarboxylase analyses
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Homeostasis of intracellular pH in bacteria has many facets, and their importance
in maintaining that balance depends on whether it was gram-negative or gram-positive.
Most bacteria use membrane ATPases in which protons were removed from the
cytoplasm to initially lower the intracellular pH. These mechanisms have a higher
magnitude of importance in homeostasis of gram-positive bacteria (11, 38). Another
mechanism shared by both gram-positive and gram-negative bacteria for pH homeostasis
was the decarboxylation of certain amino acids. Extracellular amino acids brought into
the cell, such as glutamate, lysine, and arginine, can be converted into excreted products
after decarboxylation. Intracellularly, this process creates CO2 but more importantly, also
consumes a proton which leads to the reduction of intracellular pH. The exchange
products for glutamate, lysine, and arginine were γ-aminobutyric acid, cadaverine, and
agmatine, respectively. These different amino acid decarboxylases in gram-negatives
have different preferences of induction depending on phase of growth and pH of the
surrounding media. In E. coli, the glutamate decarboxylation system was one of two
amino acid decarboxylation sytems utilized at pH 2.5 (130, 131, 133). Francisella
novicida U112 has genes for encoding glutamate and lysine decarboxylases, but not for
arginine decarboxylation, unlike other species of Francisella (www.biohealthbase.org).
In a traditional glutamate decarboxylation system, the two genes gadA and gadB
encode for isoenzymes responsible for decarboxylation of glutamate. In. E. coli, these
isozymes were induced separately depending on pH and growth stage, and in some cases,
both enzymes were functioning to decarboxylate glutamate. The gene gadC encodes the
glutamate / γ-aminobutyric acid antiporter responsible for both the import of glutamate
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Figure 25 A and B. The internal and external glutamate decarboxylation assays on
F. novicida U112 and capB mutant. Rice et al. (130) has described the measurement of
glutamate decarboxylation activity using both internal and external GAD assays. The
GAD reagent has bromoscerol green which reacts with the level of pH. A) The internal
assay (with Triton X-100) was a measure of the activity of glutamate decarboxylases
present inside the bacterial cell. Both the capB mutant and the U112 wildtype have
similar internal glutamate decarboxylase activity, as shown by the light green color. E.
coli acts as a positive control for the internal measurement. B) The external reaction
(without Triton X-100) was a measure of the exchange of glutamate / GABA at the
antiporter of the inner membrane. It was here that a difference was seen between the
capB mutant and the U112 wildtype, as the wildtype was a slightly deeper shade of blue
than the capB mutant. Again, E. coli acts as a positive control and K. pneumoniae acts as
a negative control.
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into the cell and the export of γ-aminobutyric acid out of the cell. Rice’s GAD assays
(130) for measurement of internal and external glutamate decarboxylation were used to
determine the relative levels of glutamate decarboxylation in both our wildtype U112 and
the capB mutant. Overnight cultures (1.8 ml) of both strains were centrifuged and
resuspended in 500 µl of GAD reagent and incubated at 37°C for at least four hours.
GAD reagent with Triton X-100, which permeates the outer membrane, measures internal
glutamate decarboxylation while GAD reagent without Triton X-100 allows analysis of
glutamate transport. These mixtures will turn from yellow to blue for a positive reaction
and turn clear in a negative reaction. DH5α E. coli was used as a positive control and
Kiebsiella pneumoniae was used as a negative control. Upon mixing and incubation,
both the U112 wildtype and the capB mutant turned from yellow to green with the GAD
reagent plus Triton X-100, demonstrating a slightly positive reaction. With the GAD
reagent without Triton X-100, however, the U112 wildtype produced a slight shade of
blue while the capB mutant was close to clear, similar to the negative control. These data
show that while both bacteria seem to have functioning and similar internal glutamate
decarboxylation activity, the U112 wildtype has a greater capability for neutralizing the
surrounding environment outside the inner membrane than the capB mutant.

Comparison of ESI/MS results from extracts
Due to the lack of evidence for the presence of PGA in our Francisella
preparations, I turned to the sensitive method of liquid chromatography / mass
spectrophotometry (LC/MS) to detect PGA.
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As a positive control, PGA from B.

licheniformis was compared to our samples extracted with sodium acetate / glacial acetic
acid. Schneerson et al. (148) provided the details of her analysis of PGA-conjugates that
were used to elicit antibodies to the capsule of B. anthracis. The analysis of these
conjugates was by MALDI-TOF LC/MS (148). Dr. Connell Cunningham, a senior
scientist from Rohm and Haas, a subsidiary of Dow Chemical, volunteered to perform
ESI ionization MS on three samples: 1) PGA extraction from B. licheniformis, 2) PGA
extraction of wildtype U112 grown in 1M NaCl, and 3) PGA extraction of our capB
mutant grown in 1M NaCl. The first image was PGA from B. licheniformis, which
presents m/z (mass/charge ratios) of 187 and 433, thought to be direct evidence for
glutamic acid and polymer (Fig. 26). The peaks of 269 and 515 were thought to be these
same structures but with acetyl groups attached (plus 82 m/z units from the original data).
This was attributed to the sodium acetate / glacial acetic acid used in the extraction
procedure. The second and third images were of wildtype U112 and capB mutant,
respectively, have many peaks, but none that resemble the actual peaks seen on the PGA
standard. There arguably could be small peaks at 187 and at 433 for the wildtype U112,
but these same peaks were also seen with our capB mutant, and the intensities were very
low (<100). Major peaks of the extracts from the wildtype U112 and the capB mutant
were identical. Many of the peaks in both U112 and the capB mutant also have acetyl
groups associated with them, some with multiple groups. There may be some peaks
unique to both the capB (peak 437.2) and the wildtype U112 signatures, or that the
corresponding peaks in the opposite graph were at intensities too low to determine in
these graphs. This data demonstrates that the extracts produced at 1M NaCl growth with
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Figure 26. ESI mass spectrophotometry on PGA extractions from 1M NaCl. ESI
mass spectrophotometry was performed on a PGA standard from B. lichenformis and on
bacterial-surface extracts (using a sodium acetate and glacial acetic acid procedure) from
wild-type F. tularensis U112 and its capB mutant grown in CDM at 1M NaCl. The
analysis did not show the signature profile of the PGA standard in F. novicida, nor were
there any obvious differences between U112 and the capB mutant.
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both the U112 and capB mutants were very similar to each other and do not share
properties seen in the analysis of the PGA standard from B. licheniformis. The analysis
of additional samples by Dr. Cunningham would have been helpful, but as these samples
were performed free of charge, I was unable to procure his services for additional work.
Other PGA extracts were submitted to the VCU Mass Spectrophotometry Center,
however, no intelligible data was obtained.

Amino acid analysis on bacteria samples and extracts
To further analyze extracts procured from both the wildtype U112 and the capB
mutant, samples were sent for analysis to the University of California at Davis Amino
Acid Laboratory. Initially, our PGA extracts of both bacteria grown in TSB-C, then
subjected to pH 4 as well as SDS lysates of both bacteria grown in the same conditions
were submitted for free amino acid analysis. These samples were mixed 1:1 with 6%
sulfosalicylic acid, which acts to deproteinize the sample, then centrifuged at 14K,
filtered through a .45 µm PTFE filter, adjusted to pH 2.2, and then loaded into a
Biochrom 30 amino acid analyzer. The PGA extracts from both bacteria only resulted in
quantitations for O-phospho L-serine (256 vs. 227 nmol/ml for U112 and capB,
respectively) (Fig. 27).

O-phospho L-serine, also called L-phosphoserine, was a

metabotropic glutamate receptor agonist and was structurally very similar to L-glutamate.
The SDS lysate samples demonstrated some unusual differences, also no difference seen
in L-glutamic acid (4 vs. 3 nmol/ml for U112 and capB, respectively). There were,
however, some large differences in which the U112 values were higher than the capB
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mutant (L-glutamine, 43 vs. 20 nmol/ml; L-tyrosine, 194 vs. 43 nmol/ml; and β-alanine,
27 vs. 12 nmol/ml), and others, where the capB values were larger (L-aspartic acid, 6 vs.
43 nmol/ml; glycine, 86 vs. 123 nmol/ml; L-leucine, 284 vs. 386, and L-phenylalanine,
117 vs. 170 nmol/ml). The amino acids potentially involved in pH homeostasis were
glutamic acid and L-lysine (173 vs. 216 nmol/ml).
Additional free amino acid analysis was performed on samples from both strains
grown in TSB-C, but centrifuged, decanted, and resuspended in M9 minimal medium
plus 1% cysteine, then incubated for five hours at 37°C with shaking.

This was

performed due to prior phenotypes seen with this process (e.g. the immunoelectron
micrographs) and the lack of additional amino acids in this media, which I hoped would
simplify our results. I also prepared these samples by simply centrifuging, boiling the
pellet for five minutes, and recentrifuging to collect both the lysate and the pellet. This
was done to avoid any interference due to the SDS. As recorded, the pellet volume for
U112 was 473 µl and the pellet volume for capB was 455.8 µl. As far as L-glutamic acid
was concerned, there did not seem to be any differences between wildtype and capB in
the lysate fraction (4.7 vs. 5.3 nmol/ml) (Fig. 28). There was, however, a difference seen
in the supernatant fraction (1.2 vs. 2.5 nmol/ml; wildtype > capB) and in the pellet
fraction (4.6 vs. 3.3 nmol/ml; wildtype < capB). The amino acid profiles for the lysate
and the pellet were fairly consistent with each other, except perhaps the L-phosphoserine
in the pellet fraction (0.9 vs. 0.1 nmol/ml). Other differences seen in the supernatant
fraction were as follows: L-asparagine, 1.8 vs. 5.7 nmol/ml: glycine, 16.9 vs. 30.0
nmol/ml; L-tyrosine, 1.1 vs. 8.9 nmol/ml; and L-lysine, 2.5 vs. 10.4 nmol/ml.
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To examine the total amino acid profiles of these M9 treated bacteria, the pellet
and supernatant samples were dried slightly in a SpeedVac, then transferred to 10ml
ampules for hydrolyzation. Two mls of 6N HCl (containing 200 nmol/ml norleucine as
an internal standard) was added, then purged with nitrogen gas for 5 min, and sealed
using an open flame. The ampules were then heated at 110°C for 24 hours, cooled, and
then purged again with nitrogen gas to dry. 10 ml of 0.2M lithium citrate loading buffer
was used to dissolve the samples, filtered through a 0.2 µm filter, and loaded into the
Biochrom 30 Amino acid analyzer. The glutamic acid data from the total acid analysis
was as follows: supernatant has 113.1 vs. 135.6 nmol/ml (wildtype < capB) and the pellet
has 5.95 vs. 4.73 µmol/ml (wildtype > capB). There were not as many discrepancies in
the total supernatant data as in the free amino acid data. However, I did note that Laspartic acid was 52.0 vs. 67.6 nmol/ml and L-lysine was 23.1 vs. 32.4 nmol/ml. Amino
acid data for the pellet fraction that were divergent: L-aspartic acid was 5.00 vs. 3.92
µmol/ml, L-alanine was 4.96 vs. 3.64 µmol/ml, and L-lysine was 4.17 vs. 3.31 µmol/ml.
There was some data pointing to an increase in free glutamic acid in the supernatant of
the mutant and of total glutamic acid in the pellet of the M9-treated experiment of the
wildtype U112. However, there seems to be a decrease in glutamic acid in the total
amino acid analysis of the supernatant when compared to capB. The glutamic acid data
from the SDS-lysate pH 4 subjugation experiment was inconclusive.
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Figure 27. The free amino acid analysis profiles for both PGA extracts and SDS
lysates performed under pH 4 condtions. PGA extractions from bacteria subjected to
pH 4 as well as SDS lysates under similar conditions were submitted to the Amino Acid
Analysis Facility at UCDavis. There were no significant amino acid profiles seen for the
PGA extracts, which only resulted in approximately 250 µM of O-phospho-L serine for
both bacteria. Several amino acid differences were seen of the SDS lysates, however,
glutamate concentration comparisons were unremarkable (4 vs. 3 nmol/ml for U112 and
capB, respectively).
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Figure 28. The free and total amino acid analysis profile for bacterial lysates,
pellets, and supernatants from both bacteria grown in TSB-C, then treated with M9
minimal media plus 1% cysteine. Although not enough samples were run to perform
statistical analysis, the glutamate data for the free amino acid analysis fraction of the
wildtype U112 supernatant presented double the amount of glutamic acid seen in the
capB mutant, but these levels were generally low. Other supernatant differences include
L-aspargine, glycine, L-tyrosine, and L-lysine. The only difference seen in the free
amino acid pellet profile was O-phospho-L-serine. The total amino acid profiles
demonstrated a slight difference in glutamic acid in the pellet (5.95 vs. 4.73 µmol/ml,
wildtype > capB) and a slight difference in the supernatant (113.1 vs. 135.6 nmol/ml,
wildtype < capB).
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CHAPTER FOUR: DISCUSSION

As stated earlier in this work, the capsule of Francisella has been an enigmatic
entity for some time, and many researchers have attempted to discern its existence, its
characteristics, and more importantly, its role in pathogenesis. Francisella was one of the
most infectious organisms due to its infectivity and information regarding its unique
ability to invade and persist in host cells, as well as its ability to evade both the innate and
the adaptive immune system, would be valuable. Genetically, information regarding
virulence genes of the pathogenicity island has vastly improved our knowledge of
potential regulators as well as genes essential to intracellular survival.

There was,

however, a paucity of information on effectors and structural components of the outer
membrane of Francisella (7, 16). Such information could be used to aid in the design of
potential vaccine targets as well as potential antimicrobial peptides.

Although the

weaponization of infectious agents has been prohibited by most governments, the impact
of such a bioweapon attack on any civilization would be catastrophic, and the
consequences of being ill-prepared could alter the way we live. Use of other bioweapons
in the recent past have been limited in scope, however, as the anthrax attacks in
Washington D.C. of 2001 demonstrated that although prophylaxis would not be available
to all, subsequent treatment of those potentially infected proved effective and that
although the dissemination was not extreme, the radius of exposure was greater than
initially predicted.
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There was limited data on the structure of the outer membrane of Francisella.
Extractions have been performed on the lipopolysaccharide of Francisella novicida and
these experiments have uncovered many aspects that vary from the structure of E. coli
LPS. It was known that the LPS from Francisella does not elicit the intense cytokine
response from target cells via interaction with the TLR-4 receptor as other gramnegatives do, which has been attributed to differences to the absence of a phosphate
group on the lipid A molecule as well as differences in glycosylation. It was known that
this lack of phosporylation at the lipid A molecule gives Francisella resistance to
polymyxins (62). It has also been determined that most of the lipid A molecules of the F.
novicida membrane were without core or O-antigen polysaccharides (180, 184). These
free lipid A molecules could be the source of other structural moieties of the outer
membrane. Differences have also been noted in the acyl composition of the lipid A
molecule, with Francisella not only missing an acyl group on the third hydroxyl but also
having longer fatty acid chain groups (12-14 for E. coli vs. 16-18 for Francisella) (179,
181).

Another structural component not fully understood was the aspect of phase

variation of O-antigen polysaccharides. Blue variants of LVS have been described that
have demonstrated greater virulence in animal models. These colonies, under certain
conditions, such as passage through particular cells or continued culture, can appear to
change morphology to what was known as the grey variant, with reduced virulence in
animal models. It has been determined that this phase variation from blue to grey can be
a change in the composition of the O-antigen chains of the LPS or modifications to the
lipid A molecule itself, or potentially both. It was believed that Francisella novicida was
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not subject to this phenomenon (40, 65). Such variations can influence intracellular
survival and responses to both innate and adaptive immune processes (62). It has been
shown that Francisella with certain O-antigen profiles were able to promote greater
induction of nitric oxide, thus increasing intracellular killing.
The other known structural form on the outside of Francisella bacteria was the
polysaccharide capsule, which has been characterized as possessing mannose, rhamnose,
galactose, and two forms of fatty acid (68). These sugars were of a different composition
than the O-antigen chains, and were sure to alter the outer moieties seen by aspects of the
immune system (111). Although this encapsulation can be created in vitro via passage of
bacteria in Chamberlain’s defined media, neither the ingredients nor the in vivo
conditions in which encapsulation predominates were known. It was thought that this
capsule was an extracellular phenomenon and influences virulence as has been shown by
both Chamberlain and Golovliov (30, 57).

It has been difficult to attribute the

characteristics of this structure, as capsule mutants have not been well characterized.
Sandstrom’s detailed work with Francisella mutagenized via acridine orange treatment as
capsule mutants were believed to have been O-antigen mutants by several researchers. It
was thought that the polysaccharide encapsulation enables these bacteria to be
phagocytosed easier.

It was believed that the mechanism of action for Francisella

engulfment into monocytes was the polysaccharide: scavenger or mannose receptor
interaction (35).

Perhaps the polysaccharide moieties of this capsule enable these

bacteria to be easily recognized and thus, engulfed by macrophages.

It has been

suggested that this capsule itself may have a role in the escape of these bacteria from the
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phagolysosome and may act as a cascade signal to initiate intracellular growth. Clemens
et al. (35) demonstrates that Francisella requires both complement and complement
receptor interaction for the engulfment of bacteria by macrophages. There may be some
interaction between complement and the capsule of Francisella which still eludes us.
The properties of polyglutamic acid (PGA) would make it a superb virulence
factor, and as it has been shown in several gram-positive bacteria to aid in minimizing
immune reactions, avoiding phagocytosis, effectively protect bacteria in stringent
periods, and perhaps act as a source for trophism. The fact that the genes responsible for
PGA synthesis were present and working in Francisella was great evidence for the
existence of a PGA encapsulation as does many of the phenotypes presented by the
absence of one or several of these genes. The generation of minicell E. coli with
exogenously expressed cap genes was used to determine that the proteins of cap A, B,
and C were all isolated from membrane fractions after trypsinization (107). This data, as
well as the evidence of PGA production from E. coli reengineered with exogenous cap
genes, demonstrates that PGA can be produced from bacteria other than gram-positives
(9, 72). The cap operon itself from the pOX2 plasmid of B. anthracis was flanked by
IS231 insertion sequences, and theorhetically may be able to move from genome to
genome. This initially may be how this sequence has ended up in so many different,
unrelated bacteria.
As stated before, there have been many different transposon systems which have
been developed for use in Francisella, including those used by the Kawula, Nano, and
Weiss labs. Many of these, however, frequently were limited in genomic coverage and
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have low transformation efficiencies (sometimes 1 mutant per 108 CFU). There also have
been problems with the stability of many of the Tn5 based systems (54, 76, 104). As for
our purposes, I was not interested in the creation of a mutant library and the genetic
targets in which I was interested were already known. Therefore, I decided to investigate
methods of site-directed mutagenesis to create our mutants in genes thought to be
responsible for PGA capsule biosynthesis. Traditionally, many researchers have used the
Maier series of plasmids (105) as models for suicide vectors for use in mutagenesis of
Francisella. These vectors were initially designed as shuttle vectors between Francisella
and E. coli and were still predominately used in most complementation of allelic
exchange experiments in Francisella. These plasmid insertions were thought to be stable
once in Francisella, but were limited in the methods of transformation. It was also found
that working with these plasmids was not as easy as planned, as insertions of Francisella
genomic DNA could periodically become reorganized upon propagation (105). Also, in
order to use these plasmids as a suicide vector, several modifications were necessary such
as the removal of ORFs responsible for plasmid replication in Francisella. Dr. Michael
Harwich was credited with the addition of an oriT sequence in the pFNLTP7 plasmid so
that it could be used in conjugation experiments for transformation. Two elements
missing from these series of plasmids was a Francisella promoter to drive the kanamycin
resistance cassette in single copy and a levansucrase gene (sacB) used as a
counterselection marker so that resolution of the integrated plasmid sequence out of the
Francisella genome would be possible, resulting in our unmarked deletion of our target
gene (19). Due to problems attempting to correct for these changes however, I acquired
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the targeting construct pGIR457 from Dr. Ramakrishnan through a material transfer
agreement (MTA). She used the construct to create her mutant of the fslA gene in LVS.
This construct contained both the Francisella nuo promoter which could be used to drive
the kanamycin antibiotic cassette as well as the sacB gene as a counterselection agent.
Growth of the merodiploid colonies on sucrose-containing media will select for excision
of the plasmid DNA. Correct recombinants were then screened for loss of the antibiotic
resistance but loss of the gene of interest.

Simple insertion of our Francisella

homologous DNA for capB via ligation of our PCR products into pGIR457 minus the
fslA DNA also was difficult (162).
At this time, I acquired both Francisella novicida U112 and plasmids pKEK 887,
898, 923, and pKEK 1118 from Dr. Karl Klose via an MTA. The first three plasmids
were basic target insertion constructs with the antibiotic cassettes erthryomycin,
kanamycin, and chloramphenicol, respectively.

The plasmid pKEK1118 was the

construct used to ablate the iglB gene in Francisella novicida. All of these constructs
have the FTN_1451 promoter driving their respective antibiotic cassettes as well as the
universal primer sites, UniUP and UniDN, flanking the antibiotic cassettes.

These

constructs were capable of nonpolar mutations of any targeted gene, given the correct
flanking sequences. As F. novicida is easier to manipulate genetically than its peers, I
began to customize flanking regions of capB for insertion. Looking at the plasmid
sequence of pKEK series, I determined that I could amplify the erythromycin cassette
from pKEK887 with the universal primers and using PCR SOEing, link the antibiotic
cassette with the capB flanking regions to create a single sequence. Once this sequence
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was created, I used a basic E. coli vector such as pBlueScript SK + as our backbone
construct to create the suicide vector pEF25. This also allowed us to utilize blue / white
screening of recombinants (94).
In the past, I had attempted many methods for transformation of our vector DNA
into

Francisella,

to

include

triparental

conjugations,

cryotransformation,

and

electroporation (54). The triparental conjugation experiments were time-consuming and
not very effective, although other site-directed mutants have been created using this
technique.

It seems, however, that conjugation was a more effective method of

transformation for species such as F. holarctica and F. tularensis. Cryotransformation
was also attempted with limited success using transformation buffers with both
magnesium sulfate and rubidium chloride to create Francisella competent cells. Liquid
nitrogen as well as dry ice in ethanol was used in these processes (14, 120). Shuttle
plasmids were transformed, but I had no successful attempts with suicide vectors. I
ultimately used the electroporation technique of LoVullo et al. (97) to correctly transform
F. novicida with pEF25.

Electroporation easily was the more effective method of

transformation of Francisella, although it does present problems of potential
aerosolization of bacteria, which may not be an option if using type A organisms. It
involves the creation of competent Francisella via washes in 0.5M sucrose, and these
cells can be stored at –80°C for extended periods of time without losing their competence
(97).

Our electroporation efficiency for the creation of our capB mutant was

approximately 10%, which was lower than what was experienced by Klose using
cryotransformation in his creation of the iglB mutant (94).
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The mutant was verified through RT-PCR of isolated RNA for primers specific
for capB as well as positive controls of other neighboring genes, including the immediate
downstream transcript of capC. Its presence in both the wildtype U112 and the capB
mutant demonstrated that the mutation created was indeed nonpolar, so that ideally, any
change in phenotype seen could be attributed to the loss of capB. To also ensure that
plasmid DNA had not inserted elsewhere in the genome, or that there may be an
inadvertent insertion of our antibiotic cassette someplace else in the genome, Southern
blotting of the capB DNA was performed and validated by the singular presence of our
antibiotic cassette in the capB gene (data not shown).
It was seen with the reengineered E. coli that the PGA production was much
lower than what was seen with other Bacillus species, in the range of 24 mg/L. These
genes were under the direction of the pTrc promoter of the expression plasmid (9). Jiang
et al. (72) was able to produce greater amounts of PGA (3.7 g/L) with his reengineered E.
coli expressing the PGA genes of B. subtilis by maximizing culture conditions and using
the constitutive promoter of the D-amino acid aminotransferase gene of Geobacillus
toebii. There has been no detailed characterization of the promoter region of the PGA
genes in Francisella, and although it has been shown that there was active expression at
this location via microarray data, there was no knowledge of the type of regulation of
these genes. I used many of the culture conditions known to aid in the biosynthesis of
polysaccharide production as well as traditional conditions known to increase PGA
production in bacteria such as Bacillus and Staphylococcus epidermidis.
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Our initial visual analysis for the production of PGA via classical light
microscopy with nigrosin was negative as well as attempting to use colony morphology
growth on Congo Red plates (91, 128). It was apparent from our nigrosin stains of
wildtype bacteria that I would not be able to use this technique as a diagnostic for the loss
of PGA. This was due to the relative small size of the bacteria, the lack of specificity of
the technique (PGA vs. polysaccharide), as well as the potential low production of PGA.
Due to the fact that F. novicida does not appear to form as many O-antigen chains as
LVS, F. novicida was able to bind greater amounts of the dye than LVS and presents a
deep red, crimson color vs. the lighter pink of LVS (179). Variable shades of pink were
also possible due to changes in O-antigen composition as was seen with phase variation.
It was thought that if there was extracellular membrane production of PGA that its
polyanionic nature would prevent the binding of this dye, resulting in lighter color
colonies of the wildtype U112 in comparison with the capB mutant. This, however, was
not seen as both bacteria were similar in both color and colony morphology, even at the
highest magnification possible. Even in experiments with both 1M NaCl and 50mM Lglutamic acid, there still was no apparent morphological difference between these two
bacteria.
Our experiments with sodium deoxycholate, however, pointed to there being an
ionic exchange difference at the membrane between the wildtype U112 and the capB
mutant.

As stated before, this detergent has been used to elucidate ionic barrier

differences in O-antigen mutants of Francisella (39, 91). With the statistical difference
seen between these two bacteria at the higher sodium deoxycholate levels, there appeared
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to be ionic differences. It was unclear whether this difference was due to lack of polymer
at the cell surface allowing greater permeability for the detergent or perhaps a subcellular
difference in charge responsible for this phenomenon. Measurement of the voltage
potential between the membranes of these bacteria may uncover whether this occurrence
was strictly due to charge differences in the bacteria. Other experiments such as the acid
resistance assays and the growth advantage seen with culturing in high NaCl media may
be explained by differential properties of ion exchange between the two bacteria. There
could be many possibilities for this potential electrical potential difference (131). It was
well established that modifications to the murein lipoproteins, which act as a bridge
between the peptidoglycan layer and the outer membrane, can cause changes in
membrane permeability and electrical potential. Alterations to selective porins could also
cause such changes. Perhaps additional membrane permeability experiments could be
performed to clarify this hypothesis.
The results from our serum sensitivity assays suggest that there was no protective
difference between the wildtype U112 and our capB mutant when treated with
preimmune serum. Serum sensitivity was usually a measurement of complement’s ability
to first bind to the bacterial surface and then become activated to form MAC complexes.
Complement’s ability to bind to the surface was usually blocked by the O-antigens of the
LPS, although base components of the LPS were known to help activate complement.
Neither the interaction nor the effects of the binding of complement and the capsule of
Francisella were known.

It was known, however, that complement as well as

complement receptors have an integral role in opsonization and phagocytosis of these
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bacteria (35). The capsule mutants of Sandstrom were shown to be serum-sensitive and
many of these mutants survived by being phagocytosed prior to MAC complex formation
(140). As stated above, however, these mutants were now thought to be O-antigen
mutants. A recent finding was that Francisella was capable of binding factor H, which
helps in the inactivation of the alternative pathway. It was believed that Francisella
intrinsically has defense mechanisms against both the classical and alternative pathway
for complement activation (18, 34). It was not known whether encapsulation of the
bacteria either by PGA or polysaccharides would influence the level of complement
killing or the mechanism of action via factor H. In B. anthracis, PGA capsule mutants
were shown to be phagocytosed in the absence of complement, suggesting that the
binding of complement was not essential for phagocytosis (25). It has been shown,
however, that PGA does protect against some aspects of the innate immune system such
as protection of S. epidermidis from defensins and neutrophil granules, which tend to be
cationic in nature (79).
Our data demonstrated a decrease in intracellular replication of our capB mutant
vs. the wildtype U112 when infecting RAW 264.7 murine macrophages at both two hour
and 24 hour timepoints. Although I saw an increase in CFU of our wildtype bacteria at
MOI 100 after two hours, I believed the overall difference in CFUs was due to properties
of these bacteria in regards to their intracellular replicative abilities, not a difference in
binding and engulfment by macrophages. In theory, the PGA encapsulated wildtype
bacteria should have reduced numbers of bacteria engulfed by the macrophages (79).
This was seen with the lower amount of PGA production of S. epidermidis in comparison
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to that of B. anthracis. If both bacteria had equal intracellular replicative potential, there
should be lower numbers of bacteria in our wildtype preparations when compared to the
capB mutant, due solely to the reduction in engulfment. CapB mutants of LVS have been
shown to have lower bacterial burdens in infected animal models, both in co-infections as
well as direct comparative studies between wildtype and mutant bacteria.

Catheter

infections of capB mutants in S. epidermidis resulted in reduced bacteria isolated from
these sites in in vivo murine subcutaneous models when compared to wildtype. These
reductions were independent of any biofilm formation. Similar Francisella mutants of
intracellular growth have also displayed both reduced bacterial burdens in animal models
as well as reduced in vitro macrophage infection.

There were, however, some

Francisella mutants which display in vivo attenuation without differences in intracellular
replication (186). Differences in dissemination potential could also cause a difference
between these two variables.

It should be noted that purified PGA was found to

disseminate to the liver and spleen, specifically to Kupffer cells, sinusoidal endothelial
cells, and splenic macrophages, all known targets of Francisella infection (163, 164).
Therefore the reduced bacterial burden in animal model experiments could be the result
of both reduced intracellular replication as well as reduced dissemination.
The reduced level of PGA production in S. epidermidis may be an excellent start
to determine whether Francisella was capable of producing a PGA capsule. This bacteria
has already shown that it produces PGA at a much lower level than most of the Bacillus
species (1.2 ug/L vs. 5-10 g/L), and most of our initial work shows that if PGA was being
made by Francisella, it may be in an amount less than S. epidermidis. Our initial
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immunoelectron micrographs with both bacteria grown in either TSB-C or CDM media
have no specific reactivity when using the antibodies against PGA. There was diffuse
material with gold particles localized seen in these immunoelectron micrographs, which I
believe was capsular material. However there was no loss of either the gold particles or
the diffuse material in the mutant preparations. Gold particle localization to the diffuse
material seems more specific in the F26G3 antibody preparations than the polyclonal to
B. pumilus.

There were many different media supplementations as well as culture

conditions used to try to induce PGA production in Francisella.

Many of these

conditions presented secondary phenotypes seen which would suggest the production of
PGA. These conditions include growth at high NaCl concentrations (1M+), stationary
growth at low pH (pH 4), and resuspension in minimal media plus 1% cysteine.
However, for most of these conditions, there was no differential seen in immunoelectron
micrographs between the wildtype and the capB mutant.

It was unlikely that any

polysaccharide encapsulation of Francisella would render a PGA capsule undetectable by
immunological methods as the PGA capsule of S. haemolyticus was still visible with or
without polysaccharide encapsulation (49). It also provides support for the biosynthesis
of two very different polymers for encapsulation in the same bacteria, depending upon
culture or environment.

It was not known how much PGA was produced from S.

haemolyticus, but it was stated that it was on the level of its relative S. epidermidis.
It was shown that our capB mutant had growth defecits when grown in 1M NaCl
or higher in both TSB-C and CDM. This was very similar to the data seen with S.
epidermidis, in which the PGA capsule was suggested to aid in the binding of water
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molecules due to its anionic nature. However, it was also suggested that there may be
other methods of protection provided by PGA, due to the limited amount made by this
bacteria. One simple aspect was that in the gamma linkage reaction by the amide ligase
between glutamate residues, a water molecule was generated.

This water molecule

would, in itself, increase the turgor pressure inside the cell (25, 48). There were instances
of polyglutamylation of various proteins and other molecules in order to make them more
hydrophilic. Certain tRNAs have been shown to undergo such modification as well as
eukaryotic microtubules. In the case of microtubules, the addition of several glutamate
residues to an existing glutamate residue of α- or β-tubulin takes place under certain
conditions. Polyglutamylation of tubulin was thought to increase the affinity of tubulin
for specific MAPS (microtubule-associated proteins) and has been shown to important in
centriole stability as well as axonemal motility. This phenomena, however, has not been
shown in prokaryotic bacteria, only in eukaryotes. Nor has any clear consensus sequence
for polyglutamylation been discovered, although sites of polyglutamylation usually occur
at acidic stretches of amino acid sequence containing glutamate (178). Another instance
of polyglutamylation to stabilize molecules was the polyglutamylation of folate
derivatives by folyl-polyglutamate synthease. It has been shown that four to seven
glutamate residues were added to tetrahydrofolate to increase the transport properties of
this important coenzyme (64). Such modification of enzymes could be an additional
component to surviving growth in high salt and other harsh environments and may be
direct or indirect in which chaperone proteins could be modified to protect against the
denaturation of other proteins.
125

There were many facets to osmoprotection which should be discussed. Most
enterbacteriaceae, as non-halophilic bacteria, have a salt tolerance up to 1.5 M. Several
of the gram-positive bacteria can withstand slightly higher salt concentrations due to
increased peptidoglycan. Also bacterial membrane integrity was partially dependent on
cations interacting with both the negative components of LPS as well as the anionic
amino acids of the peptidoglycan layer (38). For most gram-negative bacteria, as the
environment becomes more hypertonic, the bacteria initially attempts to compensate for
the solute imbalance by increasing the intracellular potassium ion concentration. In
response to this influx of potassium, the cell induces creation of glutamate to mainly act
as a counterion to the rise in potassium (21). Potentially, our capB mutant may have
deficiencies in this arena as well, perhaps unable to import or create this level of
glutamate internally, or unable to maintain a steady pool of glutamate to counteract the
potassium. Deficits in internal glutamate during periods of hyperosmolarity have resulted
in reduction of growth. The internal pool of glutamate was maintained by the action of
three

enzymes:

glutamate

synthetase,

glutamine

synthetase,

and

glutamate

dehydrogenase. The cycle between glutamine and glutamate has been described as
glutamine being the internal barometer of nitrogen availability and glutamate being
responsible for up to 88% of the cell’s nitrogen (189). In addition, high levels of
intracellular potassium were not healthy for the cell, and upon long periods of high
osmolarity, different molecules were used as substitute counterions, for the potassium
was then effluxed. Different compatible solutes can be used by the same bacteria and
some of these include glycine betaine, ectoine, choline, and trehalose (77).
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It was

believed that the uptake and synthesis of these molecules can be dependent on potassiumglutamate levels. It was not known whether polyglutamylation has any effect on this
form of regulation.

Cyclic ionic amino acids, such as proline, tend to increase in

concentration during these stressful periods and act as compatible solutes (98). Could the
amide ligase be responsible for a cyclic form of glutamate, similar to β-glutamate by
being metabolically inert, yet functions as a counterion? In marine methanogens, salt
tolerance was maintained by using both α- and β- forms of glutamate as counterions to
potassium.

The β-glutamate was unique in that it was not incorporated into other

proteins due to its configuration. It has been described as a compatible solute that was
metabolically inert (135, 136).
Very little information has been obtained regarding iron limitation and its effects
on Francisella. The discovery of siderophoric molecules for Francisella was a fairly
recent find and it was still uncertain how these siderophore-iron complexes were acquired
by the bacteria, as only one potential iron transporter gene has been discovered upon
genomic analysis. It has been shown that iron-starvation of LVS in Muller-Hinton broth
minus iron requires an overnight incubation prior to analysis for iron-deplete growth,
whereas F. novicida did not require such prestarvation. It has been suggested that
different species of Francisella may have various methods for retaining iron (42, 90,
162). The anionic nature of PGA would suggest that perhaps it was used to sequester or
even attract cationic molecules. It was known that ferric iron binds to PGA better than
ferrous, and that this binding was primarily based on the oxidation state of the iron ion,
although aerobic conditions also favor ferric binding (109). Studies have demonstrated
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that, of the various cations usually present in media, the ferric iron has the highest affinity
for PGA compared to its peers, followed by calcium. Another phenomenon seen with
cation-capsule mixtures from B. licheniformis was the reduction in pH without the
capsule. The interaction between the anionic amino acid and the metal ion would release
a proton, lowering the pH of the mixture (110). Overnight cultures of both our strains
would usually result in the capB mutant having a slightly lower pH than its wildtype
counterpart. Further work was required to determine whether this was due to cationcapsule interactions.

Additionally, metal-binding to anionic capsule may alter its

structure and other properties inherent to PGA. As far as magnesium was concerned,
there was no difference seen in the growth curves between our wildtype U112 and the
capB mutant. It has been shown that increases in MgCl2 have increased PGA production
in species such as Bacillus. The magnesium was used by the ATPase in the formation of
the polymer. Concentrations as low as 1mM of MgCl2 have been shown to be adequate
for PGA production in B. anthracis and in the reengineered E. coli. I tested incremental
concentrations from 0.5 to 200 mM of both MgCl2 and MgSO4 and no evidence of PGA
production was evident, nor was there any difference in growth between the two bacteria.
Although manganese has been shown to be an adequate substitute for magnesium at a
much lower concentration (µM vs. mM), and, in some cases, produces more PGA than
MgCl2, similar experiments performed with MnCl2 were as unproductive (6, 9).
Our overnight growth curve experiments with various concentrations of sodium
bicarbonate and 10% carbon dioxide caused increases in the pH of the media as expected,
which was the probable cause for the differences seen in the amount of growth. It was
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reasonable to believe that the increase in bicarbonate made the media too alkaline for
optimal growth. Interesting, the pH of the capB mutant was consistently lower than the
pH of the wildtype U112. These findings will be addressed in the acid resistance section
of this document.

The increase in bicarbonate also increased the viscosity of the

supernatant for both bacteria, which was collected for further study. The carbon dioxide
was used in anaplerotic CO2 fixation reactions by Bacillus to maintain the balance of
many precursors to nucleotides and amino acids, such as oxaloacetate and αketoglutarate. These were both intermediates in the tricarboxylic acid cycle and αketoglutarate was one of the key components in the synthesis of glutamate. It was
believed that Francisella could possibly use similar anabolic pathways for the genesis of
glutamate for PGA biosynthesis. It seems, however, that the viscous material isolated
from the supernatants was mostly sugars from the polysaccharide encapsulation. Both
the wildtype U112 and the capB mutant had similar viscosities and anthrone assay
measurements.
As described earlier, many different capsule isolation techniques were attempted
to procure PGA from our strains under different culture conditions.

The majority,

however, of these procedures required multiple ethanol precipitation steps, in which most
ionic polymers would aggregate including polysaccharides and PGA. It was not known
whether PGA production in Francisella, if possible, was secreted or attached to the outer
membrane or peptidoglycan layer (24, 26). Many of the PGA isolation procedures for
bacteria such as B. licheniformis were techniques applied solely to the supernatant.
Conversely, there also were procedures in which the supernatant was removed and PGA
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isolation was performed as washes to the bacteria itself. And without an inexpensive and
accurate measure for PGA, our selection criteria for an extraction were limited.
However, after narrowing our selection down to the B. anthracis PGA isolation of Dr.
Chabot and the B. anthracis PGA isolation of Dr. Kozel, I isolated our samples using the
Kozel technique. This sodium acetate / glacial acetic acid procedure would allow us to
collect material from both the supernatant and washes from the bacteria, and as stated
previously, our limited analyses from these samples were consistent. These samples were
stored at –20°C as several papers cited the degradation of PGA polymer without frozen
storage.
As with many of the immunoelectron micrographs performed under various
conditions, larger scale inoculations of bacteria under similar conditions were used in
order to isolate PGA from these bacteria. Immunoblots were performed on bacterial
extracts at 1M NaCl, 50mM MgCl2, 10% CO2 plus sodium bicarbonate, stationary
growth at pH4, and controls. None of the wildtype U112 extracts produced positive
signals with the monoclonal anti-PGA F26G3, which was shown to have reactivity with
B. licheniformis, but not B. subtilis. There were signals seen for the wildtype U112 at
most of these conditions with the polyclonal, but usually there was no differential
between the wildtype and the mutant. This polyclonal was against B. pumilus and was
used in similar experiments in immunblots with S. epidermidis. It has been stated that
this bacteria only produces a fraction of the PGA seen in other Bacillus species, yet the
polyclonal was able to discern PGA production between a capB mutant and wildtype S.
epidermidis (79). The control blot demonstrated reactivity of the polyclonal with PGA
130

from both B. licheniformis and B. subtilis. With the following data, there may be limited
specificity with the polyclonal as it seems to bind slightly to all of our extracts (controls,
wildtype, and deletion mutants). More information about these antibodies would be
beneficial to being able to discern the data presented, as no crossreactivity experiments
with these antibodies has been performed against various forms of PGA. Another bit of
information which would be useful was the extent to which these antibodies can bind and
the specific epitope profile. The PGA formed from the control bacteria was usually
composed of polymer of larger MW, such as 100-1000 kDa. Candela and Fouet (25)
show antibody-PGA interaction at intervals of 36-38 nm. It was not known what length
of polymer was necessary for stable antibody interactions.

Was it possible that

Francisella was capable of short polymer production, which would provide many of the
properties discussed so far, yet unable to interact with antibodies designed against larger
structures?

Antibodies to B. licheniformis, which produces (D+L) PGA filaments,

recognizes PGA produced from B. anthracis (D), but would it recognize the rarer (L)
PGA filaments produced by some organisms? Greater information was needed regarding
the crossreactivity abilities of these antibodies and the extent of interaction depending on
polymer length.
Most of the protection mechanisms described for protecting bacteria during
periods of high osmolarity will apply to desiccation as well. Due to the prolonged nature
of desiccation, the dynamics of potassium-glutamate should only apply to short-term
exposure. Long exposure to slow desiccation under aerobic conditions would involve
oxidative stresses and protection of necessary proteins. The accumulation of compatible
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solutes highly benefits this situation and work by the suggested hypothesis of preferential
exclusion. The thought was that the build-up of these preferably metabolically inert
molecules, which can be at low molar levels of concentration, were not in contact with
essential proteins and molecules. This “exclusion” creates a water layer of the remaining
water molecules around proteins so that it is energetically favorable for the protein to
maintain its conformation and configuration (123). Francisella does not possess genes
for sporulation yet has a substantial desiccation tolerance when compared to other
persistent bacteria such as Mycobacterium tuberculosis, Yersinia pseudotuberculosis, and
Moraxella bovis. Indeed, Francisella has been shown to have comparable desiccation
tolerance to Streptococcus pyogenes and Corynebacterium diphtheriae (155). There was
a lack of dipicolinic acid in Francisella, however it was believed that there were other
aspects to Francisella which give it unique persistence characteristics.

In our

experiments, I did not see CFU formation at our standard dilution of 10-8 after three days.
These results were seen after incubation in minimal media plus 1% cysteine.
Reproduction of this experiment in a further reduced media may increase our desiccation
potential, or perhaps a lower dilution. It has been shown that for Francisella, persistence
was greater when the level of relative humidity was low. In fact, these bacteria have been
shown to have the lowest survival rate at high relative humidity in aerosol experiments
when compared with several of its peers (155).

Although our experiments were

performed in a dry incubator at 30°C, perhaps further timepoints could be achieved by
reducing the ambient humidity. Another aspect of desiccation was the extent of nutrient
starvation that can occur. It is known that glutamate was usually the source of most
132

nitrogen in the bacterial cell. Could short oligmers of PGA act as a storage stockpile for
additional nitrogen and carbon in times of nutrient starvation? Another gene which has
shown a similar importance as far as virulence in animal studies was cyanophycinase,
which in cyanobacteria was responsible for the breakdown of cyanophycin in times of
nutrient starvation as a nitrogen reserve (55). As can be expected, there was a paucity of
information on desiccation of any the bacteria on the select agents list. The resuscitation
of Francisella after particular stresses was another factor to consider, as passage through
an animal system has been shown in several types of bacteria to be necessary after
experiencing stringent conditions for viability. The plating of the desiccation-stressed
bacteria onto rich media agar may not provide the appropriate conditions necessary for
colony growth. Additional CFUs may have been demonstrated on another agar type,
such as cysteine heart agar with defibrinated blood.
One of the interesting phenotypes I experienced with the capB mutant was the
acid resistance of the wildtype U112. Most neutralophiles can tolerate growth in media
within a range of pH from 5 to 8. Some of these bacteria have developed systems to exist
at a slightly greater range, however, the internal pH must remain between 6.5 and 7.5 to
avoid damage to organelles and macromolecules (11). Potentially, I learned that several
of these responses to external stimuli could be related. There was evidence, in the case of
E. coli, that changes in external sodium levels may have an effect on pH homeostasis
(132). There were many integrated systems involving passive and facilitated ion flux at
the membrane, external and internal stimulation resulting in induced or repression at the
transcription level, proton movement at the membrane, and potential post-translational
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modifications. The decrease in external pH initially results in influx of potassium, thus
resulting in the efflux of protons via the potassium / H+ antiport system in an attempt to
increase the intracellular pH. It was important to remember that the cell will attempt to
maintain the proton motive force so that protons will flow down its gradient into the cell
in order to produce ATP. Also, the influx of potassium will create a similar scenario to
high osmolarity, as internal glutamate production will be induced as well as increased
influx of this amino acid to counteract the positive potassium. As the media decreases in
pH, most enteric bacteria use amino acid decarboxylation systems to maintain its
intracellular pH. The E. coli model was the standard for these systems as it utilizes three
different amino acid decarboxylation mechanisms to maintain pH homeostasis. These
systems include arginine, lysine, and glutamate decarboxylation. Each of these amino
acids was decarboxylated to agmatine, cadaverine, and γ-amino butyric acid (GABA),
respectively.

Each of these systems has different methods of induction and was

preferentially used in different stages of growth (17 ,28). F. novicida has only two of
these systems, lysine and glutamate decarboxylation. The glutamate decarboxylation
system was the most robust of the three and was used in periods of low pH (<3) and in
stationary phase. The decarboxylation reaction itself consumes an intracellular proton
and all of these systems rely on substrate exchange, so that in the case of glutamate
decarboxylation, glutamate was converted to GABA, which was then exported out of the
cell in exchange for fresh glutamate.
There were also several different regulatory factors which were thought to be
involved in controlling these reactions. Regulatory elements such as RpoS, PhoP, and
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Fur have been shown to modulate and induce acid shock proteins which were used to
physically deal with damage to macromolecules from exposure to low pH (88). It was
interesting to note that the Fur protein appears to have both the ability to repress ironrelated genes as well as activate acid shock genes independent of iron. The PhoP / Q
system was a two-component system which has been demonstrated to be important in
intracellular survival, but that PhoP can also act as an acid shock protein. It was not
known whether a Francisella analog has been annotated for this two-component
regulatory system (139). RpoS, on the other hand, was responsible for regulating a host
of genes necessary for stationary phase, low pH, oxidative stress, and heat tolerance.
RpoS has shown increases in translation but not in transcription in response to changes in
concentration of inorganic fatty acids, which was directly related to the internal:external
pH gradient. It was believed that these inorganic acids as well as anionic molecules such
as polyamines can be directly responsible for increases in the amino acid decarboxylation
system (27, 73). Polyamines were polycationic molecules such as spermine, cadaverine,
and putrescine, which can be generated de novo or taken in from the environment, and
can reach millimolar concentrations inside the cell. Some of these polyamines were
potential byproducts from the amino acid decarboxylation reaction themselves. Jung and
Kim (73) have published research on E. coli which indicates that polyamines have a
negative effect on cAMP levels, which in turn, has a negative effect on glutamate
decarboxylation. Polyamines have also been shown to scavenge oxygen free radicals
which were created due to the modifications in pH and aeration. Therefore, they were
involved in the protection of both nucleic acids and proteins. It has been demonstrated in
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Streptococcus pneumoniae that uptake of polyamines increases due to increased
production of polyamine transporters during periods of oxidative stress. Polyamines have
also been implicated in decreasing outer membrane permeability, enhancing
phagolysosome stability, and promoting apoptosis of polymorphonuclear cells (151).
Specifically, the glutamate decarboxylation system was made up of enzymes
responsible for the decarboxylation event and the antiporter which effluxes the byproduct
of the reaction as well as influx of fresh glutamate at the inner membrane. In E. coli, two
genes encode two versions of glutamate decarboxylase (gadA, gadB) and the antiporter
(gadC). In F. novicida, only one gene has been annotated as a glutamate decarboxylase
(FTN_1701) and the antiporter has been suggested to be encoded by FTN_1529.
Mutations in these types of genes produce organisms that have limited acid resistance.
Also in E. coli, it has been shown that the sodium ion concentration has influence on
gadX and gadW. These two gene products were known to regulators of gadE, which was
a direct activator for the glutamate decarboxylation system. The sodium ion influence on
these two regulators appears to be posttranscriptional. Therefore, the same influx of
sodium experienced during exposure to 1M NaCl or the indirect sodium increase due to
desiccation could also potentially modify the activity of glutamate decarboxylase or the
exchange of glutamate for GABA (100, 102, 132). Dr. Foster’s experiments with the
GAD assay provides two types of information. First, by sampling bacteria with the GAD
reagent with Triton X-100, one was able to determine the relative level of glutamate
decarboxylation intrinsic to that bacteria via the cytosolic process, ie. gadA, gadB. The
decarboxylation of glutamate results in the consumption of a proton, the generation of
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CO2, and GABA. Sampling of the bacteria with the GAD reagent without Triton X-100
measures the ability of the bacteria to exchange the substrates, ie. gadC. It was thought
that GABA exchange also will help to neutralize the surrounding media (28, 130). Our
data demonstrated that while both the wildtype U112 and capB had the capability to
decarboxylate glutamate, the capB had a reduced ability to neutralize acidity outside the
inner membrane. This reduced ability may explain the mutant’s reduced growth in our
acid resistance studies as well as the difference in pH of inoculations between the two
bacteria. Could the reduced ability for capB to exchange substrates in the glutamate
decarboxylation process result in reduced intracellular glutamate during these periods of
acid stress? Mutants of the reengineered E. coli without the cap operon demonstrated a
reduced amount of radioactive internal glutamate when compared to E. coli with the cap
operon (107). If there was a differential in glutamate / GABA exchange, it may be
interesting to determine whether the lack of influxing glutamate or lack of effluxing
GABA or both was the source of acid sensitivity seen. It has also been shown in the E.
coli system that synthetic glutamate analogs have acted as inhibitors to this system as
well (185). Our data from the acid resistance experiments demonstrated that Francisella
does not seem to have a functioning log phase acid resistance system. Although some of
these systems have been implicated in log phase protection, other mechanisms apparently
have greater importance (perhaps ATPases or a functioning arginine decarboxylation
system).
Another aspect of pH homeostasis should be considered and discussed as well.
There have been experiments performed in which the conversion rate of glutamate to
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Figure 29. Model of glutamate decarboxylation in E. coli. This image demonstrates
the relationship between glutamate decarboxylation activity and the exchange of fresh
glutamate for GABA at the antiporter of the inner membrane. Many different control
mechanisms were thought to be involved in the regulation of glutamate decarboxylation,
such as polyamines, cAMP, and RpoS involvement.
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adopted from Jung I. L. and Kim I. G. Journal of Biological Chemistry 278:22846-52
139

GABA was compared to conversion of arginine to agmatine, resulting in a 3:1 ratio. It
has been proposed that this greater ratio was necessary due to the chemistry involved in
the decarboxylation reactions.

The site of decarboxylation for glutamate was the

carboxyl side chain which has a pKa of 4.25. Simply stated, this group will remain
protonated at pH < 4.25. One of the largest objects of discussion amongst acid resistance
researchers was that as glutamate enters the cell in a low pH media, this R-group will be
protonated, only to lose that proton once inside the cell, as the pH will probably be higher
than 4.25. It was believed that decarboxylation then occurs, consuming that proton in the
conversion to GABA. Many feel that there was some aspect to the system which was
missing, as there wasn’t a net loss of protons upon GABA exchange. Proponents of the
utility of this system believe that the ratio of decarboxylation was the key to this
conundrum, or perhaps, additional utilization of de novo glutamate which was protected
from deprotonation prior to decarboxylation. Still another theory was that glutamine can
also participate in this exchange and that glutamine dehydrogenase occurs first to create
intracellular glutamate, which was then decarboxylated. The pKa of the R group of
glutamine was 8.18, which means that this group would probably be protonated at most
physiological conditions.
The capability of acid resistance for many pathogenic bacteria provides them with
the ability to pass through harsh environments such as the host’s stomach in the case of
Salmonella and hemorrhagic E. coli, to survive in acidic foods such as Listeria
monocytogenes, or to survive phagolysosomic acidification in macrophages or PMNs (11,
92).

It has been thought that the passage of Francisella in the pathogenesis of
140

macrophages was that, after looping phagocytosis by the cell, the bacteria escape from
the early endosome shortly after lysosome fusion. It has been shown that no acidification
of these vesicles was necessary for escape and that this acidification was arrested (35,
144). These transitions were observable due to specific markers used for identification
the maturation stages of phagolysosomes and visualization by immunoelectron
microscopy. Early endosomal markers such as EEA-1 were seen in infected vacuoles
very early in infection and subsequent turnover of these markers for LAMP-1 does occur,
but at a fairly low frequency, with less than 20% of infected bacteria inside vacuoles
positive for LAMP-1 by one hour of infection. The majority of bacteria were found in
the cytoplasm, where for the next four to 24 hours, replicate in the cytoplasm. It was
believed that the multiplied bacteria then signal for apoptosis of the host cell and escape
to infect other cells. However, a seminal paper by Checroun provided evidence of entry
of these bacteria into autophagic vacuoles hours after infection and that these vacuoles
were acidified, staining positive for LAMP-1 and cathepsin D. Both of these markers
were indications of lysosome fusion and acidification (31).

These bacteria-filled

vacuoles were also positive for MDC or monodansylcadaverine, an autophagic probe,
and LC3, an autophagosomal membrane-associated protein.

Additional proof of

acidification of these autophagic vacuoles was the accumulation of LysoTracker Red
DND-99 dye, which permits estimation of the pH of the vacuoles. It has been suggested
that this method of intracellular trafficking may be dependent on IFN-γ activation. In
addition, autophagic processes have been observed to occur as early as one hour after
infection.
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The knowledge of this transition, however, may provide insight into the virulence
of the wildtype U112 when compared with the capB mutant. I have experienced several
phenotypes which have demonstrated the acid resistance of the wildtype. This resistance
has been shown to occur after stationary phase growth as there was no growth seen at low
pH (pH 4) during log phase growth. These conditions would be very similar to the
pathogenesis of Francisella in macrophages. It was thought that Francisella did not
require genes necessary for acid resistance due to the fact that the bacteria were found to
escape the phagolysosome prior to lysosome fusion.

This premise must now be

reexamined as these genes now may be necessary to allow Francisella to survive
residence in these autophagosomes. Francisella does possess lysine decarboxylation
genes in addition to the glutamate decarboxylation machinery and could potentially use
both of these mechanisms to protect itself while in the autophagosome. As Francisella
does not seem capable of growth at these low pHs, it would make sense to escape such
exposure early in infection, but once the bacteria have replicated to a suitable number (ie.
after cytoplasmic replication), survival at low pH would give these bacteria an
appreciable advantage. This information would help explain the reduction of bacteria in
the capB mutant in our macrophage infection model as well. With the inability to
withstand the low pH of the autophagosome, replicated bacteria of the capB mutant
would be subject to hydrolases once entering the autophagic pathway. It was not known
how the lack of an amide ligase would result in reduced glutamate exchange, thus
reduced acid resistance. It was also not known whether the autophagic process was
mediated by the bacteria or by the host, as examples of both scenarios do exist (41).
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Another question that requires investigation was iron acquistion for the replicating
bacteria. It has been shown that acidification promotes the release of free iron and was a
must for many intracellular pathogens in order to acquire iron. Perhaps the siderophores
produced by Francisella were transiently required during intracellular replication and
other, less efficient iron acquistion methods were necessary during autophagosome
residence (162).
Our ESI/MS submissions suggest that the 1M NaCl data for our wildtype U112
and capB extracts did not resemble the mass/charge profile for PGA from B.
licheniformis. Limited identification of the source of the peaks for the wildtype U112
and capB can be made and comparison to MS data from LPS samples from the literature
was not informative (181). Additional separation of our extracts via the use of ionic
columns does not seem to have been necessary for comparative analysis.

Perhaps

additional submissions of other environmental conditions may have shed some insight
into the structures of the components in these extracts as well as additional controls for
PGA.

In the Schneerson paper, the PGA samples were derivitized with

heptafluorobutyryl isobutyl esters after hydrolysis with HCl, and were separated by HP-5
0.32x30 mm glass capillary column (148). Perhaps separation and derivitization was
necessary for accurate analysis of PGA polymers. It seems that the derivitization allowed
for the determination of the different enantiomers of glutamic acid. There again, there
was a lack of information on mass spectrophotometry of PGA for us to draw any
conclusions from our previous data, other than the extract samples of our two bacteria
were very similar and that they do not resemble the PGA profile of B. licheniformis.
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Our survey of the free amino acid demonstrates no glutamic acid or any typical
amino acid for that matter in the PGA extract of either bacteria at pH 4. There were,
however, substantial amounts of L-phosphoserine found in these extracts, which was
structurally similar to L-glutamate. Analogs to glutamate have been shown to inhibit the
glutamate-dependent acid resistance system. It has been shown that 1.5mM of L-transpyrrolidine-2, 4-dicarboxylic acid (L-PDC) can significantly inhibit the in vitro glutamate
decarboxylation of E. coli (185). This blockage takes place at the glutamate / GABA
exchange antiporter (gadC) and was found to be strictly competitive.

Perhaps L-

phosphoserine was having a similar effect in our acid resistance studies, acting as a
competitive inhibitor to glutamate and disrupting the glutamate decarboxylation cycle.
Additional tests could be performed to determine if this was a likely scenario. There was
limited information on the specificity of the gadC antiporter but such information could
be useful to identify potential glutamate analogs that may obstruct this system.

I

consistently see a difference in L-phosphoserine in favor of the wildtype U112, at pH 4
and with the minimal media. The SDS samples show an increase in glutamine when
comparing the U112 to the capB mutant, which may be an indication of glutamine
utilization for decarboxylation.

Again, a greater understanding of Francisella’s

glutamate / GABA antiporter was necessary. The minimal media data presented both a
difference in free glutamic acid when comparing the supernatants and the pellet fractions.
If PGA were part of the supernatant fraction, one would expect the glutamic acid content
to favor the wildtype. The pellet fraction presents a lower glutamic acid amount for the
mutant when compared to the control, however, this may be due to PGA, another source
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of polyglutamylation, or just a difference in free glutamic acid. The other amino acid
potentially involved in acid resistance was lysine, in which I consistently see higher
amounts in our mutant supernatant samples than in the wildtype. This trend may also
warrant additional attention as this resembles what was seen with glutamate in the
supernatant. Analysis of the total amino acid data also demonstrates higher amino acid
content of glutamate and lysine in the supernatant fraction for the mutant, as the pellet
information paralleled the free amino acid profile for glutamate. As with the MS data,
additional studies were needed to draw more substantive conclusions regarding PGA
production.
Many different experiments have been performed by various researchers, both
Bacillus and Francisella alike, to determine whether Francisella was capable of
producing a capsule consisting of polyglutamic acid. Under the conditions tested, it
seems that the existence of a PGA capsule for Francisella was still enigmatic, although
these studies may have clarified some of the idiosyncrasies which make Francisella such
an efficient pathogen of cells such as monocytes and macrophages. It was still unclear
how the loss of a gene such as an amide ligase can result in a reduced potential for
replication in macrophages as well as reduced potential to survive desiccation. It may be
possible that gene has an additional function other than the γ-bridging of glutamic acid.
Further tests should be able to discern this, as radioactive studies using isotopic glutamate
or glutamine may not elucidate the existence of a PGA capsule, but may clarify the
glutamate:glutamine equilibria of these bacteria. Studies into the glutamate / GABA
antiporter should also be performed to determine whether there actually was a differential
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in activity of that inner membrane protein. As mentioned before, a greater knowledge
and repetorie of antibodies specific for different forms of PGA would be useful, as
visualization immunologically may be still be possible. And it could stand to reason that
the appropriate conditions for polymerization have not been discovered. Investigation
into the expression levels of the genes potentially responsible could also elucidate which
conditions favor expression as would access to steady mass spectrophotometry. As
isolation of these membrane complexes was rather difficult, some proteomics research of
recombinant proteins may uncover affinities and relationships with other inner membrane
proteins, which may clarify the poly-γ-glutamate synthetase complex’s potential role, if
any, in Francisella.
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